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ABSTRACT OF DISSERTATION

STRUCTURAL INSTABILITY OF HUMAN RIBOSOMAL RNA GENE CLUSTERS
The human ribosomal RNA genes are critically important for cell metabolism and
viability. They code for the catalytic RNAs which, encased in a housing of more than 80
ribosomal proteins, link together amino acids by peptide bonds to generate all cellular
proteins. Because the RNAs are not repeatedly translated, as is the case with messenger
RNAs, multiple copies are required. The genes which code for the human ribosomal
RNAs (rRNAs) are arranged as clusters of tandemly repeated sequences. Three of four
catalytic RNAs are spliced from a single transcript. The genes are located on the short
arms of the five acrocentric chromosomes (13, 14, 15, 21, and 22). The genes for the
fourth rRNA are on chromosome 1q42, also arranged as a cluster of tandem repeats.
The repeats are extremely similar in sequence, which makes them ideal for
misalignment, non‐allelic homologous recombination (NAHR), and genomic
destabilization during meiosis , replication, and damage repair. In this dissertation, I
have used pulse‐field gel electrophoresis and in‐blot Southern hybridization to explore
the physical structure of the human rRNA genes and determine their stability and
heritability in normal, healthy indIvIduals. I have also compared their structure in solid
tumors compared to normal, healthy tissue from the same patient to determine
whether dysregulated homologous recombination is an important means of genomic
destabilization in cancer progression. Finally, I used the NCI‐60 panel of human cancer
cell lines to compare the results from the pulsed‐field analysis, now called the gene
cluster instability (GCI) assay, to two other indicators of homologous‐recombination‐
mediated genomic instability: sister chromatid exchange, and 5‐hydroxymethyl‐
2’deoxyuridine sensitivity.
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CHAPTER 1: BACKGROUND AND INTRODUCTION
1.1 HOMOLOGOUS RECOMBINATION
In mammals, DNA double strand breaks (DSBs) arise by a variety of mechanisms.
During meiosis, they are generated by Spo11, which facilitates the alignment of parental
homologues [ Baudat F et al 2000; Keeney S and Neale MJ 2006; Fledel‐Alon A et al
2009]. They occur in mitotic cells as a result of stalled or collapsed replication forks or
replication fork barriers during DNA synthesis . Single strand breaks which are not
repaired prior to synthesis also generate DSBs when the affected region is replicated.
DSBs can also result from exogenous damage such as ionizing radiation or chemicals
which generate inter‐and intrastrand crosslinks or covalently bound adducts [reviewed
in Ohnishi T et al 2009].
DSBs are repaired by non‐homologous end joining (NHEJ) or homology‐directed
repair (HDR), depending on a variety of factors, including when the DSB occurs
[Shrivastav M et al 2008]. Briefly, NHEJ involves excision of DNA to generate
complementary ends which are ligated together. Although it is the most common and
efficient means of repairing a DSB, NHEJ is not error‐free. Some DNA is excised during
this type of repair as the two ends are generated, causing a small loss of genetic
information [Weterings E and Chen DJ 2008; Mao Z et al 2008; Rothkamm K et al 2003].
HDR, on the other hand, is considered to be error‐free, and involves either the
borrowing of genetic information by one sister from the other, or the actual physical
exchange of DNA between sisters in order to effect the repair [Richardson C et al 1998].
In this chapter, I will explore eukaryotic HDR, some of what is known of the human
genetics involved, and the consequences of malfunctioning or dysregulated repair,
paying particular attention to mitotic recombination and the potential for genomic
instability and cancer. There are numerous reviews on this subject, as evidence of
somatic HDR and its importance has emerged over the last dozen years [Moynahan M
and Jasin M 2010; Helleday T 2010; Reliene et al 2007].
The nomenclature associated with HDR is confusing and sometimes inconsistent
in the literature. A few initial clarifications are necessary. For the purposes of the work
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presented here, I consider a “double‐strand break” as any two‐stranded DNA molecule
that is discontinuous within a chromosome, including, as previously mentioned, a
replicated region of DNA which originally contained a single‐break. A DSB does not have
to possess frank blunt ends. Strictly speaking, the DSBs that arise by Spo11 during
meiosis are physiologic, rather than pathologic, and referring to those breaks as
“damage” is not accurate. They are resolved by homologous recombination (HR),
however.
An exploration of meiotic versus mitotic HR and the differential regulation of
each is not germane to the data presented here, and thus HR may be referred to as
“repair” within the context of either mitosis or meiosis. I consider homology‐directed
repair (HDR) as any repair of a DSB which utilizes homologous sequence, whether from
the sister, the parental homolog, or non‐allelic and not necessarily homologous location.
Pathways of HDR include synthesis‐dependent strand annealing (SDSA), homologous
recombination (HR) with and without crossing over, single‐strand annealing (SSA), and
break‐induced replication (BIR).
In the literature, HR with and without crossing over is often referred to as
“canonical DSB repair,” and the term “homologous recombination” is sometimes used
to describe any form of HDR. For the sake of clarity, in this work, HR refers to the
canonical DSBR pathway of HDR, specifically the repair of a DSB by means of double‐
Holliday junction formation and resolution which may or may not result in crossing over
and the physical exchange of DNA between sisters, homologues, or non‐allelic
sequences.
E. coli and S. cerevisiae are convenient organisms in which to study HR; and
much of the modeling and biochemistry in the literature is based on experimentation in
yeast and bacteria, although regulation of HDR and its pathways is obviously quite
different in more complex organisms such as humans. Although the experiments and
results presented are conducted entirely in human subjects or human cancer cell lines, it
is impossible to avoid using S. cerevisiae references to generate the necessary context in
which to interpret this data.
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The initial steps are common to the two major mammalian HDR pathway
models, SDSA and HR. First, the DSB is recognized and processed to create single‐
stranded DNA with a 3’‐hydroxyl overhang. In mammals, this is performed by the MRN
complex which tethers the free ends to keep them near each other and, in the case of
post‐replicative repair, near the identical sister [Lavin MF 2004; Moreno‐Herrero F et al
2005; Hopfner KP et al 2002]. The 3’ overhangs are coated by RPA [Wang X and Haber JE
2004]. This process is not yet fully characterized in humans or other mammals, but is
known to involve CtlP, BLM, BRCA1, and EXO1, as well as other unidentified proteins
[Reviewed in West SC 2003; Hartelrode AJ and Scully R 2009]. It is thought to be
regulated by cyclin‐dependent kinase 1 (Cdk1) which restricts the mechanism to the S
and G2 phases [Ira G et al 2004]. RPA prevents the ssDNA from forming secondary
structures which would prevent HDR from proceeding [Sung P et al 2003]. RPA is
subsequently displaced and, in a reaction mediated in mammals by BRCA2, RAD51 is
loaded onto the single‐stranded DNA (ssDNA) to generate a protein‐coated filament
[San Filippo J et al 2006].
Next, the RAD51‐coated filament invades the homologous duplex DNA and
displaces the identical strand, generating a displacement loop (D‐loop). Although NHEJ
repairs the vast majority of DSBs during G1 and early S, RAD51 knockout is lethal in
mice, giving some indication of the critical role RAD51‐catalyzed HDR for genome
stability and survival [Rothkamm K 2003]. Either SDSA or HR ensues thereafter,
depending upon whether or not the D‐loop, which migrates, captures the second free
DNA end. About 50% of the time during meiosis, and 90% of the time during mitosis, the
second free end is not captured by the D‐loop, resulting in the SDSA pathway being
preferred, yielding repair without cross‐over [Bzymek M et al 2010]. These findings are
not unexpected, given the fact that during meiosis, the chiasmata associated with
cross¬overs help to ensure appropriate segregation and are thus permitted [Hunt PA
and Tassold TJ 2002]. During mitosis, however, inappropriate cross‐overs may
potentiate genomic instability and are therefore very infrequent in non‐malignant
dividing cells.
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In the SDSA model, once the RAD51‐coated filament has invaded the duplex
DNA, a single Holliday junction (HJ) is formed and migrates as new DNA is synthesized
along the homologous template (Figure 1.1). At some point following extension, the
invading strand is displaced and reanneals with the end from the original broken
molecule.
In the HR model, sometimes referred to as canonical DSBR, the second free end
is also captured by the D‐loop, resulting in the formation of two Holliday junctions
(Figure 1.1). Synthesis takes place at both of the free ends, using both strands of the
unbroken homologous duplex as template. The Holliday junctions can migrate along the
DNA, either extending or decreasing the size of the region of heteroduplex DNA
(annealed duplex DNA comprised of two strands of DNA from different origins). It is this
double‐Holliday junction DNA conformation which presents the possibility for the
physical exchange of DNA known as crossing‐over. If these HJs are “dissolved” by BLM‐
Topo III, no cross‐over product is generated. If the HJs are “resolved”, in a process
which involves cleavage of DNA, a cross‐over product may result [Bzymek M et al 2010;
Wu L and Hickson ID 2003; Colavto S et al 2010]. As we have noted previously, this is a
very rare occurrence in mitotic cells, but a consequential one. It is this pathway, HR with
cross‐over, with which we are concerned. The data presented in this work explores the
results of dysregulated or erroneous cross‐over.
Single‐strand annealing (SSA) is another HDR pathway in humans and other
mammals but is distinct from HR and SDSA in that it is not catalyzed by a RAD51‐coated
filament‐mediated strand invasion. SSA requires regions of repeated sequence flanking
the DSB. Once the 5’ ends are resected, regions of homology are exposed and aligned,
followed by removal of non‐homologous ends, DNA synthesis, and ligation. The genetic
information between the repeated regions is lost during this process [Pastink A et all
2001].
Break‐induced replication (BIR), as it occurs in yeast, is a means for restarting
collapsed replication forks and maintaining telomeres. In both cases, there is no second
end for annealing after repair. Repeated rounds of strand invasion and synthesis must
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occur before replication can be restarted and processivity restored. BIR requires large
regions of homology which are not consistent with the organization of human DNA.
Also, because both strands of the donor are used in order to provide the template for
extending from the one‐ended recipient, BIR in humans could potentially be a source of
gross chromosomal rearrangements, and is thought not to be favored for this reason
[Smith CE et al 2007].
HDR repair processes must be tightly regulated to maintain genomic stability,
and defects associated with HDR pathways are associated with genomic instability and
cancer in humans. BRCA1 and BRCA2 mutations are perhaps the most well known of
these defects. BRCA1 is a component of several complexes at crucial steps of HDR,
including damage response, cell cycle checkpoint progression, and actual repair of the
DSB [reviewed in O’Donovan PJ and Livingston DM 2010]. The role of BRCA2 in HDR is
less varied than that of BRCA1, but its activity is not well defined. What is known is that
RAD51 recruitment for HDR requires BRCA2, and that it also assists with RPA
displacement and RAD51 loading and stabilization of the filament [Moynahan ME et al
2001; San Fillipo J et al 2006]. Tumors which manifest defects in either BRCA1 or BRCA2
demonstrate chromosomal rearrangements and aneuoploidy characteristic of loss of
genomic stability [Kraackman‐van der Zwet M et al 2002; Huen MS et al 2010]. BLM is
another HDR‐associated protein with defects associated with cancer. Bloom’s syndrome
is an autosomal recessive disease in which both copies of the BLM protein are
inactivated. These patients develop a variety of cancers very early in life [German J
1997]. Cells with inactivated BLM show 10‐fold higher number of sister‐chromatid
exchanges, which are thought to arise as a result of dysregulation of cross‐over HR.
These cells also show structural instability in the ribosomal RNA gene clusters. BLM, a
member of the RecQ helicase family, is involved in migration and resolution of Holliday
junctions, and effectively functions to suppress cross‐over during HR repair [Wu L and
Hickson ID 2003; Killen MW et al 2009]. A great deal remains to be elucidated regarding
HDR components and regulation. However, it is apparent at this point that HDR,
including HR, is vital for cell viability and genome stability. HR‐associated defects in cell
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cycle regulation, checkpoints, or damage recognition may allow proliferation with
misrepaired DSBs, leading to genomic instability. At the other end of the spectrum, a
hyperactive or dysregulated recombination mechanism may also lead to genomic
instability, as is the case with BLM, where cross‐overs are no longer suppressed.
We have recently shown evidence of extensive cross‐over‐mediated structural
instability in solid tumors from clinical cancer patients. Approximately 50% of patients
show rearrangement of ribosomal RNA gene clusters resulting in amplification or
deletion of repeat units. These results indicate that dysregulated recombination, at least
with regard to the ribosomal RNA gene clusters, is a fairly common feature of solid
tumors and begins early in tumor progression[Stults DM et al 2009].
1.2 NON‐ALLELIC HOMOLOGOUS RECOMBINATION, SEGMENTAL DUPLICATION, AND
COPY NUMBER VARIATION
It has recently become apparent that human genomic structural variation,
specifically copy number variability is an important characteristic of the hiuman
genome, and that the resulting dosage differences and positional effects likely
contribute as much, if not more, than single nucleotide polymorphisms to normal
phenotypic variation [Freeman JL et al 2006; Feuk L et al 2006; Redon R et al 2006;
Goidts V et al 2006]. A copy number variation (CNV) is defined as a copy number
change in a region of greater than 1 kilobase [Feuk L et al 2006]. CNVs can be tandem
duplications or involve gains or losses of homologous sequence from disparate regions
of the genome [Redon R et al 2006]. Several groups have pursued identification of CNVs
through various experimental approaches tailored to focus on CNVs of particular size or
characteristics. We now know that CNVs are ubiquitous throughout the genome, often
occurring in gene‐rich regions. According to one group, two individuals could vary in
total genome size by as much as 9 Mb, including as many as 1,500 genes [Wong KK et al
2007].
CNVs are often located at or flanked by segmental duplications (SDs) [Iafrate AJ
et al 2004; Sharp AJ 2005; Sebat J et al 2004]. These duplications, also called low copy
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repeats (LCRs), are regions of >1 kb which bear >90% sequence identity [Eichler EE et al
2004]. About 5% to 15% of the human genome is believed to be comprised of SDs
[Bailey JA and Eichler EE, 2006; Sharp AJ et al 2006; Gibcus JH et al., 2007; Darai‐
Ramqvist E et al., 2008; Gu W et al., 2008; Mefford HC and Eichler EE 2009]. They may
be scattered throughout the genome across many chromosomes, arranged in clusters of
tandemly or inverted oriented repeats, or both. Their repetitive nature is inherently
confounding to genome assembly strategies, making them difficult to map and
subsequently grossly underrepresented by the early Human Genome Project [Sharp AJ
et al 2005; Eichler EE 2006; Bailey JA et al 2002].
Such sequences are hotspots for meiotic non‐allelic homologous recombination
(NAHR). When homologous recombination with crossing‐over occurs between
homologous sequence in a non‐homologous context, such as misalignment of tandemly
repeated sequences, unequal crossing‐over occurs and results in duplication, deletion,
translocation, or inversion of sequence (Figure 1.2) [Shaw CJ and Lupski JR 2004; Lupski
JR and Stankiewicz P 2005]. Several heritable genetic syndromes are known to arise by
this mechanism, including 22q11.2 deletion syndrome, Charcot‐Marie‐Tooth syndrome,
hereditary neuropathy with liability to pressure palsies, Williams‐Beuren syndrome,
Prader‐Willi syndrome, Angelman syndrome, and Smith‐Magenis syndrome [Stankiewicz
P and Lupski JR Trends 2002]. NAHR is also believed to be a basis for primate speciation
and variation within the human species [Bailey JA and Eichler EE 2006]. In 2004,
Barbouti et al showed that i(17q), a common structural abnormality in human
neoplasias, likely arises by NAHR, which indicates a role for NAHR in somatic, as well as
meiotic rearrangements (Barbouti A et al 2004].
Comparative genomic hybridization (CGH) has been used to identify CNVs and to
specifically uncover regions of segmental duplication. Recently, this array‐based
approach has yielded three previously unknown loci associated with pathogenic copy
number changes in clinical cytogenetics patients [Rudd MK et al 2009]. However,
sensitivity is limited to a 3‐fold change in copy number, and this technique does not
address the genomic architecture at a given locus that gives rise to the change [Redon R
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et al 2006; Sharp AJ et al 2005. For clusters of repeated SDs, where there may be
hundreds of copies of the repeat present at a single chromosomal region, CGH does not
have the capacity to evaluate whether expansion or contraction by a single repeat is
occurring or determine the heritability or relative stability of these regions. We have
therefore developed an assay, the gene cluster instability (GCI) assay (described in
chapter 2) to specifically characterize the physical genomic structure of repeat clusters
and evaluate the level of NAHR‐mediated instability from both the meiotic and mitotic
perspective.
1.3 HUMAN RIBOSOMAL RNA GENES
This dissertation represents the use of human ribosomal RNA genes to explore
human genomic instability that arises from NAHR in SDs. Each eukaryotic ribosome
contains four RNA molecules which together do the catalytic work of translation and
peptide bond formation. They are housed in two subunits comprised of more than 80
proteins. Because these single, individual RNAs are not repeatedly translated, multiple
copies of the ribosomal RNA (rRNA) genes are required in order to generate sufficient
rRNA molecules to accomplish all of the ongoing protein translation required for
metabolism and viability in a eukaryotic cell. In S. cerevisiae, 60% of the total RNA is
rRNA [Ide S et all 2010; Doudna JA and Rath VL 2002].
In humans, the genes that code for three of the four catalytic ribosomal RNAs
are located on the short arms of the five pairs of acrocentric chromosomes (13, 14, 15,
21, and 22) [Henderson AS 1972]. The genes are contained within tandemly arranged
SDs, repeated units of 43.3 kb each (OMIM 180450‐180454) [Caburet S et al 2005;
Schofer C et al 1998; Worton RG et al 1998]. In the nucleus, the short arms of the
acrocentric chromosomes which contain these genes are arranged surrounding the
nucleolus, in a region called the nucleolar organizing region (NOR). Their isolation
allows them to be transcribed and regulated separately from the rest of the genome.
They are transcribed by Pol I to form a single, 45S transcript, which is subsequently
spliced into the 18S, 28S, and 5.8S rRNAs. [Reviewed in Bartova E et al 2010]. The size
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and extreme sequence identity of the ribosomal DNA (rDNA) repeats prevents them
from being properly assembled and mapped by the Human Genome Project, and as a
result, the rDNA clusters are one of the largest remaining components of the human
genome with no representation in the Human Genome Project. The total number of
rDNA repeats per diploid human cell, based on work from 1972, is estimated to be
about 400 copies [Henderson AS 1972].
Early quantitative hybridization studies indicated that the size of the clusters,
though polymorphic in a population, is heritable [Guanti G and Petrinelli P 1974]. This
idea was subsequently substantiated by silver staining; though the technique yields
results which are a function of both DNA quantity and transcriptional activity [ Miller OJ
et al 1976; Markovic VD et al 1978]. Although it has been demonstrated that the rDNA
clusters are subject to interchromosomal and intrachromosomal recombination, the
degree of variability and stability of the clusters in the human population has not been
directly determined [Arnheim N et al 1980; Worton RG et al 1988; Kuick R et al 1996;
Gonzalez IL and Sylvester JE 2001].
The genes for the fourth catalytic rRNA, called the 5S rRNA, are located on
chromosome 1q42. Like the 45S genes, they are arranged as clusters of tandemly
repeated units. Each repeat is 2.2 kb in length [Sorensen PD et al 1990]. According to the
Human Genome Project (build 36.2), the 5S rDNA cluster contains 17.2 tandemly
repeated units (OMIM 180420). Although the unit repeats are smaller, enabling the
chromosomal context to be determined, the size of the cluster cannot be accurately
predicted by the shotgun approach utilized by the Consortium, and thus the estimation
of 17.2 repeats is very likely a substantial underestimation. Prior to sequencing of the
human genome, one group estimated that each array was approximately 200 kb in
length and contained 90 tandem repeats of the 2.2 kb unit [Little RD and Braaten DC
1989]. Grain count analysis of seven individuals using an 125I‐labeled 5S RNA probe
showed differences indicating the region is likely polymorphic for copy number
[Henderson AS et al 1980]. The 5S rRNA genes are located in the nucleoplasm away
from the rest of the rDNA in the NOR. They are transcribed by Pol III, rather than Pol I
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[Bartova A et al 2010]. I undertook structural characterization of these genes in my
experiments with healthy human subjects to determine their stability and heritability,
but they were not included in later experiments with clinical cancer patients or human
cancer cell lines.
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FIGURE 1.1: REPAIR OF DOUBLE STRAND BREAKS BY DSBR AND SDSA

From: Mechanism of homologous recombination: mediators and helicases take on
regulatory functions. Patrick Sung & Hannah Klein. Nature Reviews Molecular Cell
Biology 7, 739‐750 (October 2006)
doi:10.1038/nrm2008
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FIGURE 1.2: EFFECTS OF NON‐ALLELIC HOMOLOGOUS RECOMBINATION

Aa) Recombination between homologous sequence in upstream and downstream
repeats which flank gene A results in duplication of gene A on one chromosome and
deletion of gene A on the other. b) Recombination between homologous sequence on
different chromosomes results in translocation. c) recombination between
homologous sequence from repeats which are inverted with respect to one another
results in inversion of the intervening sequence.
Bailey & Eichler Nature Reviews Genetics advance online publication; published online
13 June 2006
doi:10.1038/nrg1895
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CHAPTER 2: PULSE FIELD GEL ELECTROPHORESIS AND THE GENE CLUSTER INSTABILITY
ASSAY
Physical characterization of the human rRNA gene clusters was achieved by
pulsed‐field gel electrophoresis using a CHEF Mapper (Bio‐Rad) system followed by in‐
blot Southern hybridization with 5S and 45S rDNA‐specific 32P‐radiolabeled DNA
probes. The main theoretical concepts behind these techniques are described below.
Standard agarose gel electrophoresis does not resolve DNA fragments of greater
than 15kb to 20kb. A single ribosomal 45S rDNA repeat is 43.3kb, and available
literature predicts that the individual clusters may contain dozens of repeats in head to
tail fashion. Fragments of this size are exponentially beyond the capacity of
conventional electrophoretic separation. The same is true for the 5S cluster. Although a
single repeat, at 2.2kb, would easily be resolved by conventional means, a single cluster
contains a minimum of 35kb according to by the Human Genome Project, and is very
likely much larger.
Pulsed‐field gel electrophoresis technology was developed to overcome the
limitations of conventional electrophoresis. Manipulating the direction of the electrical
field, as well as the duration of the field, allows large fragments, up to 10 Mb, to be
fractionated. Rather than moving straight through the gel toward the opposite pole,
manipulating and pulsing the electrical field allows the DNA to alter speed and direction,
allowing the smaller fragments to become separated from the larger ones [Schwartz DC
and Cantor CR 1984].
Bio‐Rad’s CHEF‐Mapper XA system was used to accomplish these experiments.
The system uses CHEF (clamped homogeneous electric fields) and PACE (programmed
autonomously controlled electrodes) technology. It is comprised of a gel box which
contains 24 electrodes arranged in a hexagon. They are controlled by a computer which
allows six parameters to be manipulated: the angle of the electrical field in 5 degree
increments, strength of the field, switching of time at any given field, ramping of the
switching time as a linear, concave or convex hyperbolic function, and total run time.
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The computer also allows for programming of blocks of completely independent sets of
conditions. Field inversion (FIGE) is also an option, where the direction of the field
changes by 180 degrees, and the field strength is alternated. A free‐standing chiller unit
is connected to a sensor in the box, such that the temperature of the buffer can be
maintained during long run times. Having such a great degree of control over how the
DNA migrates through the gel allows for optimal resolution of any given size range
between 50 kb and 10 MB, and it is even possible to “zoom in” on a particular range,
providing maximum separation in a predetermined area [Bio‐Rad].
Our gene cluster instability (GCI) assay involves isolating very high molecular
weight DNA (10 Mb) from human lymphocytes, solid tissue, or cultured cells. This is
accomplished essentially by suspending intact cells in agarose, and using Proteinase K
and detergent to digest away proteins and lipids, leaving only nucleic acid lying
relatively undisturbed to minimize mechanical shearing [Jackson DA and Cook PR 1985;
Cook PR 1984]. Live cells are quantified using a Partec bench‐top flow cytometer and
acridine orange staining, in order to ensure that there is a standard concentration of
DNA per mL of agarose. DNA isolation by digestion is an overnight procedure, followed
by several rinses to dilute away the Proteinase K and detergent. In final isolation step,
agarose DNA suspension is equilibrated in glycerol to prevent it from freezing and
splintering when stored at ‐20 C.
Next, the ribosomal RNA genes, either 45S or 5S, are released from genomic DNA
by restriction enzyme digest. I use an enzyme which does not have a predicted
restriction site within a single repeat. Since the sequence of the repeats is highly
conserved, there is usually not a restriction site in any of the subsequent repeats; and
thus, the entire cluster is liberated. Enzyme digestion of approximately 1 µg of DNA in
agarose is accomplished overnight at 37 C. Depending on the efficiency of the enzyme,
10 to 20 units of enzyme in 200 µl of appropriate buffer is usually sufficient for complete
digestion of an approximately 12 µl agarose “slice” which contains about 1 µg of high
molecular weight genomic DNA.
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Digested DNA undergoes separation by pulsed‐field gel electrophoresis on the
CHEF Mapper system described above, altering the programmed parameters in order to
provide optimal resolution at the desired size range. Total run times are usually
between 20 and 48 hours.
After electrophoresis, gels are soaked in ethidium bromide to stain and provide
visualization of a standard DNA ladder, which indicates whether the electrophoresis was
successful. Very large fragments of DNA present a technical challenge at this stage of
the protocol, as well, since they do not migrate easily out of the gel and onto a
customary membrane for Southern blotting. Our approach involves leaving the DNA in
the agarose gel and dehydrating it [Tsao SG 1983; Purrello M and Balazs I 1983].
Glycerol is added to the ethidium bromide soak, to prevent the gel from shattering as it
is dried at 65 C in a hybridizing oven. Once dehydrated, the gel is very thin and supple
[Son M et al 1990; Leuders KK and Fewell JW, 1994; Ehtesham NZ and Hasnain SE 1991].
Conceptually, Southern blotting proceeds from this point much as it would under
conventional circumstances. A 32P‐labeled, human rDNA specific probe to a region in
either the 5S or the 45S sequence, is amplified by PCR, and added to a carafe containing
hybridization buffer and the rehydrated gel. Hybridization of the probe is accomplished
overnight at 65 degrees, followed by several rinses of varying stringency to wash away
the remaining probe and minimize backrgound signal. The gel is exposed on a
PhosphoImager cassette and visualized by PhosphoImager scanner.
In order to ascertain the rate of rDNA gene cluster instability in a given cell line, a
subcloning process is undertaken prior to DNA isolation. Cultured cell suspension
undergoes serial dilution plating in order to form colonies derived from a single cell.
Plates are grown up from the colonies and DNA is isolated. The “parental” plates are
also subjected to another round of serial dilution to grow up colonies from single cells.
About a dozen of these “subclone” colonies are grown up into plates and DNA is
isolated. By comparing the electrophoretic GCI karyotype of each of the subclones in
comparison to the parents and to the other subclones, we can establish the rate at
which the size of the rDNA gene clusters is changing (Figure 2.1).
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FIGURE 2.1: SUBCLONING TO ASSESS THE RATE OF GENE CLUSTER INSTABILITY

1. Cultured cell suspension undergoes serial dilution plating in order to form colonies
derived from a single cell. 2. Plates are grown up from the colonies and DNA is
isolated. 3. The “parental” plates are also subjected to another round of serial dilution
to grow up colonies from single cells. About a dozen of these “subclone” colonies are
grown up into plates and DNA is isolated.
By Michael W. Killen, University of Kentucky College of Medicine, Department of
Microbiology, Immunology, and Molecular Genetics. Used with permission.
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CHAPTER 3: DIFFERENTIAL FLUORESCENCE PLUS GIEMSA STAINING OF SISTER
CHROMATIDS
3.1: SYNOPSIS
A method is presented for measuring homologous‐recombination mediated
sister chromatid exchange. After undergoing two rounds of division in the presence of
5¬bromo‐2’‐deoxyuridine, cells are dropped onto microscope slides to generate
metaphase spreads. Fluorescence plus Giemsa staining is used to differentially stain
sister chromatids. Recombination‐mediated physical exchange of DNA between sisters is
easily visualized and quantified by brightfield microscopy.
3.2: INTRODUCTION
Homologous recombination (HR) is a mechanism for repairing double‐strand
breaks (DSBs). In contrast to non‐homologous end joining (NHEJ), which results in a loss
of genetic material, homologous recombination is considered error‐free repair because
it uses the available, identical sequence from the sister chromatid to repair the DSB. HR
is preferred for repairing the DSBs that arise at stalled or collapsed replication forks or
from replication at single strand breaks and cross‐links [Rothkamm K et al 2003].
Inhibition or deficiency of poly(ADP‐ribose) polymerase (PARP), which is involved in the
base excision repair (BER) pathway causes accumulation of single‐strand breaks but also
increases levels homologous recombination [Schultz N et al 2003; Pachkowski BF et al
2009]. PARP inhibitors can induce synthetic lethality in cells with mutations in the tumor
suppressors BRCA‐1 or BRCA‐2, which are components of the HR pathway [Kyle S et al
2008; Ashworth A 2008]. Mitotic HR is a complex, varied, and tightly regulated process,
and defects in several of the components of HR have long been associated with cancer
[reviewed in Reliene R et al 2007; Helleday T 2010].
The most established means of detecting dysregulated homologous
recombination, whether in cells with defective/deficient HR capacity, or in response to
damage, is the sister chromatid exchange assay (SCE) which differentially stains sister
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chromatids, allowing for microscopic detection of the physical exchange of DNA which
occurs with cross‐over HR [Wilson DM and Thompson LH 2007]. The SCE assay has been
in use since the 1970s for the purpose of identifying potential “chromosomal
mutagenicity” of chemical agents [Perry P and Evans HJ 1975]. Chemicals that generate
interstrand crosslinks, such as mitomycin C, are potent inducers of SCE, since HR is
required to repair the resultant blockage during replication [Thompson LH 2005].
Conditions and drugs which increase the number of single‐strand breaks (SSBs) also
increase the number of SCEs, presumably by overburdening the base‐excision repair
(BER) pathway such that unrepaired SSBs remain, become DSBs during replication, and
elicit repair by homologous recombination [Wilson DM and Thompson LH 2007].
Mutation or knockdown of BLM, which is involved in double‐strand break repair, causes
increased levels of recombination as well as a 10‐fold elevation in sister chromatid
exchange [Killen MW et al 2009].
The protocol described below utilizes 5‐bromo‐2’‐deoxyuridine (BrdU)
incorporation and fluorescence plus Giemsa (FPG) staining to make exchanges between
sister chromatids visible [Perry P and Wolff S 1974; Wolff S and Afzal V 1996]. BrdU is a
nucleotide analog which resembles thymidine and is efficiently incorporated into
replicating DNA. Since DNA replication is semiconservative, after BrdU has been made
available to cells, it is incorporated as the nascent strand is elongated. After two rounds
of replication, paired sister chromatids in the four daughter cells differ in the amount of
BrdU each contains. The sister with the original template has one strand of normal DNA
and one strand with BrdU. Both of the strands from the other sister contain BrdU.
Subsequent binding of the ultraviolet (UV) light sensitive Hoechst 33258 dye to DNA,
followed by UV light exposure, causes “bleaching” of DNA which is proportional to the
amount or incorporated BrdU in the double‐stranded molecule. Subsequent staining
with Giemsa makes the differential bleaching apparent by light microscopy (Figure 3.1
and figure 3.2) [Wilson DM and Thompson LH 2007].
Other methods for measuring sister chromatid exchange following differential
BrdU incorporation involve fluorescent imaging and the use of either acridine orange in
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place of UV treatment followed by Giemsa staining [Yankiwski V et al 2001], or an anti‐
BrdU antibody with either propidium iodide or DAPI counterstain for bulk DNA [Wilson
DM and Thompson LH 2007; Pinkel D et al 1985]. Rapid photobleaching is a potential
pitfall, however, especially with the use of acridine orange, and fluorescent filters are
required. We have achieved excellent results with optimized FPG staining (described in
this work), and prefer the convenience of brightfield microscopy and the permanence of
this staining method, including the possibility for repeated and extended viewing of the
same spread.
This protocol has been tested in a wide variety of human cancer cell lines which
have been immortalized to undergo unlimited rounds of replication. It has not been
tested by us in primary cell lines, plant cells, or non‐cultured tumor cells extracted from
donors. It is not effective for terminally differentiated cells which are not actively
dividing due to the requirement for differential BrdU incorporation.
3.3: MATERIALS, REAGENTS, AND STOCK SOLUTIONS
THAWING CRYOPRESERVED CELLS
1. Latex or nitrile gloves
2. 10‐cm tissue culture plates (or tissue culture flasks for non‐adherent cells).
3. Well characterized line adherent or non‐adherent mammalian cells.
4. Tissue culture incubator
5. Laminar flow hood with standard tissue culture setup, including serological pipettes,
micropipettes, and vacuum aspiration apparatus.
6. Inverted light microscope with 10X, 25, and 40X objectives for viewing plates of
growing cells.
7. Tissue culture medium such as Dulbecco’s Modified Eagle medium or RPMI 1640
8. 95% reagent grade ethanol.
9. Fetal bovine serum
10. L‐glutamine/Penicillin/Streptomycin 100X solution.
11. Plasmocin 25 mg/mL (for mycoplasma prophylaxis)
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STOCK SOLUTIONS
Complete culture medium: Medium appropriate for in vitro growth of cells. We typically
use MEM or RPMI supplemented with 5% to 10% fetal bovine serum, 1% Pen‐Strep and
L‐glutamine, and 1:10,000 of Plasmocin 25 mg/mL.
70% Ethanol: 95% Reagent grade ethanol diluted to 70% with sterile distilled water.
GROWING CELLS AND ESTABLISHING DOUBLING TIME
1.

Trypsin/EDTA (0.05% Trypsin, 0.53 mM EDTA).

2.

15‐mL conical centrifuge tubes

3.

Clinical centrifuge.

ADDING 5’‐BROMO‐2’‐DEOXYURIDINE
1.

5‐bromo‐2’‐deoxyuridine (BrdU) MW 307.1. Available from Fisher Bioreagents,
Catalog #: BP2508250

2.

Sterile distilled water

3.

Aluminum foil

STOCK SOLUTIONS
10 mM BrdU stock aliquots: make 200 µl aliquots and store at ‐20 C. NOTE: BrdU MUST
BE PROTECTED FROM LIGHT AT ALL TIMES IN ORDER TO AVOID UV‐LIGHT MEDIATED
FREE RADICAL DECOMPOSITION. The 10mM stock solution should be made in the dark
and stored in 1.5 mL Eppendorf tubes which have been covered with aluminum foil.
ARRESTING CELLS IN METAPHASE
Colcemid (demecolcine solution 10 µg/mL in HBSS, available from Sigma, catalog #
D1925)
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HARVESTING CELLS FOR METAPHASE SPREADS
1. Ca2+/Mg2+‐free phosphate‐buffered saline (PBS): 200 mg/L KCl, 200 mg/L KH2PO4, 8g/L
NaCl, 2.16 g/L Na2HPO4‐7H20 (Available commercially from Invitrogen as D‐PBS 1X
liquid, catalog #: 14190‐144 )
2. Potassium chloride
3. Sodium Citrate
4. Methanol
5. Glacial acetic acid
STOCK SOLUTIONS
Hypotonic Solution: 46.5 mM KCl / 8.5 mM Na⋅Citrate
3:1 methanol/acetic acid fixative: Add 1 volume glacial acetic acid to 3 volumes of
reagent grade ethanol. MAKE FRESH BEFORE EACH USE!!
PREPARING AND STORING SLIDES FOR METAPHASE SPREADS
1. Microscope slides
2. Glass Coplin jars or other glass container suitable for holding a rack with at least a
dozen slides.
3. Slide racks and containers for staining, such as EasyDip™ slide staining system
(available from ISC Bioexpress, as well as other suppliers), which allows for easy transfer
of an entire rack of slides from one solution to another.
4. Refrigeration 4 C for chilling and holding slides.
MAKING METAPHASE SPREADS
1.

Small rubber suction bulbs.

2.

5” glass Pasteur pipettes

3.

Slide warmer with adjustable temperature.

DIFFERENTIAL STAINING SISTER CHROMATIDS WITH GIEMSA
1. Hoechst 33258 98%, available from Acros Organics, catalog #: 229891000

21

2. Na2HPO4
3. KH2PO4
4. NaCl
5. UV light source: Two 20‐watt blacklight bulbs (We use F20T10BLB/RS from Sanyo‐
Denki.
6. Shaker, hybridization oven, or warm room which can be maintained at 50 C.
7. Concentrated Giemsa stain solution (50% Giemsa in methanol and glycerin), Available
from Acros Organics, catalog #: AC612051250.
STOCK SOLUTIONS
1mg/mL Hoechst 33258 in H2O (protect from light), stored at 4 C. Note: Hoechst 33258
works equally well when diluted in PBS. However, it is much less soluble in phosphate
buffers than in water.
Sorensen buffer: 0.1 M, pH 6.8: mix equal volumes 0.1 M Na2HPO4 and 0.1 M KH2PO4
20X SSC: 3M NaCl and 300 mM sodium citrate
10% Giemsa in Sorensen buffer: Add concentrated Giemsa stain solution to Sorensen
buffer such that the concentration of Giemsa stain solution (not total concentration of
Giemsa itself) comprises 10% of the total volume. It is convenient to mix this 100 mL at a
time and store in a 100 mL glass bottle protected from light. The stain solution can be
poured back into the bottle after staining and reused several times.
PREPARING SLIDES FOR VISUALIZATION
1.

Cytoseal‐60 low viscosity mounting medium

2.

Coverslips for slides: 24 x 50 x 1 mm.

3.4: METHODS
THAWING CRYOSPRESERVED CELLS
Wear latex or nitrile gloves. Wipe down the working surface of the laminar flow
hood with 70% EtOH. Add 8 mL of tissue culture medium to a 10‐cm tissue culture dish
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or flask for non‐adherent cells and warm for 5 minutes in the tissue culture incubator to
equilibrate temperature and pH.
Remove a vial of cryopreserved cells from liquid nitrogen freezer. In the laminar
flow hood, thoroughly wipe down the outer surface of the vial and gloves to limit
bacterial contamination. Unscrew the cap of the cryovial to equalize gas pressure inside
the vial with normal atmospheric pressure. Screw the lid back down to seal the vial.
Hold the vial in your gloved hand to rapidly warm the contents until partially thawed.
Remove the tissue culture plate or flask from the incubator and place it in the tissue
culture hood. When the cells are sufficiently thawed that the still frozen portion moves
freely in the tube, unscrew the cap and dump the entire contents onto the tissue culture
plate. Quickly replace the lid to the tissue culture plate and GENTLY agitate the plate so
that the frozen pellet thaws and is evenly distributed in the pre‐warmed medium. Place
the plate in the humidified tissue culture incubator and leave overnight at 37 C and 5%
CO2. Non‐adherent cells should be stored in the incubator with the flask cap in place but
not screwed tight, to permit appropriate gas and humidity equilibration.
FOR ADHERENT CELLS: The next day, vacuum aspirate the medium to remove
the cryopreservtative and dead cells. Replace with room‐temperature complete culture
medium.
FOR NON‐ADHERENT CELLS: The next day, remove the cells and medium from
the flask to a 15‐mL conical tube and centrifuge at 200 x g for 5 minutes to pellet the
cells. Aspirate medium and replace with fresh, pre‐warmed medium. Add 1 mL and
pipette up and down to disburse, then add 7 more mL. Transfer cell suspension to a new
flask and put back in the incubator.
FOR ADHERENT CELLS: Visualize the plate with 10X objective inverted
microscope to estimate survival. Cells should be checked under the microscope at least
once a day to determine the morphology of a healthy, dividing culture.
FOR NON‐ADHERENT CELLS: Flasks or plates may also be viewed with dissecting
microscope. A healthy non‐adherent culture will have perfectly round surface and
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bright, glowing edges on phase contrast. Dead cells and debris is generally irregularly
shaped and opaque. Trypan blue, and propidium iodide exclusion techniques are also
commonly used to determine the viability of a non‐adherent culture.
EXPANDING THE POPULATION AND ESTABLISHING DOUBLING TIME
Cells usually need at least one day to recover from the thawing and begin to
divide. Depending on how many cells survived freezing, expansion may be required in
concert with removal of dead cells and cyropreservative above; or, depending upon the
health of the culture and the number of cells originally frozen, cells may require a day or
two before they are ready for expansion.
FOR ADHERENT CELLS: A culture is ready for expansion when it is at about 80%
confluence on the plate. If, the day after thawing, there are only a few cells adhering to
the plate, another vial should be thawed. It should not require more than a day or two
after thawing for cells to reach 80% confluence. Ideally, at least 50% of the frozen cells
should survive thawing.
FOR NON‐ADHERENT CELLS: The medium will begin to change color from peach
to yellow as the pH becomes more acidic; the result of metabolic wastes being released
into the medium. For a healthy culture, the medium will begin to turn during the first 48
hours after thawing. Upon microscopy, the population of healthy cells should have
significantly increased in proportion to the debris observed upon thawing. Medium that
is still peach‐colored two days after thawing indicates that most or all of the culture is
dead. Check for viability via propidium iodide or trypan blue staining. It may be
necessary to thaw another frozen stock, or put cells into a smaller volume container
(such as 6‐well plate) to concentrate the suspension, as some cell lines fare better when
grown in a dense culture. Expand the population by dividing the dense culture into five
plates, wells, or flasks, and adding warmed complete medium to the appropriate
volume.
FOR ADHERENT CELLS: Once cells have reached 80% confluence they are ready
for expansion. Aspirate medium and add 2 mL of 0.05% Trypsin/EDTA to detach cells.
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Trypsin works by cleaving the cadherin proteins that attach cells to the plate and one
another. After about 2 minutes, the bottom of the plate will appear a little cloudy to
naked‐eye visual inspection, indicating that cells are beginning to “ball up” and
disengage themselves from the plate. This is visible under the microscope, as cells
become circularized and show brightly glowing edges on phase contrast microscopy.
Detachment time may vary depending upon how tightly the cells adhere to the plate,
but should not be more than 10 minutes. Once cells have begun to ball up, tap the plate
gently on the side of the hood or carefully but firmly shake it to detach the cells. Tilt and
swirl the plate to coax the cells off of the bottom of the plate.
Once cells are completely detached, add 5 mL complete culture medium
including at least 5% FBS to “stop” the action of the trypsin/EDTA. Leaving cells for an
extended period of time in Trypsin/EDTA is undesirable and decreases cellular viability.
Using a 5 mL serological pipette, remove the cells/trypsin/medium to a 15 mL conical
centrifuge tube and centrifuge for 5 minutes at 200 x g to pellet the cells.
During centrifugation, prepare five tissue culture plates with 7 mL each of room
temperature complete culture medium.
Use vacuum apparatus to aspirate the medium overlaying the centrifuged cell
pellet, taking care not to aspirate the pellet itself. Leave a small volume of medium on
top of the pellet in order to minimize the risk of aspirating the pellet.
Using a P1000 variable volume pipette (e.g. Pipetman), add 1 mL of fresh
complete culture medium and gently pipette up and down to break up and resuspend
the pellet. Add 4 mL of medium and mix by inverting in the conical tube.
Pipette 1 mL of resuspended cells onto each of the five plates and swirl to evenly
distribute. Each of the plates should contain approximately the same number of cells.
While the cells are still in suspension, BEFORE they have had a chance to settle to the
bottom of the plate, remove a few µl from at least three of the plates and determine
the initial concentration using a hemocytometer or benchtop flow cytometer with
volumentric counting to count live cells. The concentration values should not be very far
apart. Average them to approximate the initial concentration in each of the plates. This

25

is merely to get an idea of the number of cells on each plate and verify that there is
equal distribution amongst the plates.
After 24 hours, use trypsin/EDTA to harvest the cells from ONE of the plates as
before as a quantification control Count the number of cells from this plate by methods
given above. Record this value as the concentration at T0 for the remaining uncounted
plates. Remember that it takes the cells several hours to recover from plating. The initial
concentration should not be used as the value for T0.
The remaining plates should be harvested and counted at convenient intervals
less than 24 hours, such as +18 hours, +36 hours, +48 hours, and +60 hours. Record the
concentrations for each of these times and plot them on a curve to determine how
quickly the cells are dividing. Calculate the amount of time required for cells to reach a
population of approximately twice the concentration at T0. You will use this doubling
time to determine when to harvest after BrdU has been added. The process for
establishing doubling time is inexact. The objective is to get a general idea, within a few
hours, of how quickly the cells are dividing, in order to optimize the differential
incorporation of BrdU. Most immortalized human cells double about once every 24
hours in culture and adequate results may therefore be obtained by adding BrdU 48
hours before harvest. Some may proliferate substantially more rapidly or more slowly.
The effects of having added BrdU too soon or too late will not be apparent until the
procedure is complete, however; and so, especially for a new or unfamiliar cell line, it is
worth investing the time to establish how fast a particular cell line is actually dividing in
culture under your specific laboratory conditions.
ADDING BRDU FOR INCORPORATION
After having established the doubling time for the cell line of interest, split cells
into a fresh plate for growth at approximately 10% to 20% confluency
When (ADHERENT) cells appear to be 80% confluent, split and expand the
culture by dividing the cells evenly across five plates prepared as described above.
Incubate overnight at 37 C in the tissue culture incubator to allow the cells to recover.
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FOR BOTH ADHERENT AND NON‐ADHERENT CELLS: The next day, thaw an
aliquot of 10 mM stock of BrdU The tube should be protected from direct light while it is
thawing and throughout the procedure. Turning off the nearest room lights and the
fluorescent lamp in the laminar flow hood is usually sufficient.
Add BrdU to each of the four plates at final concentration of 20 µM (1/500
dilution from 10 mM stock). Gently swirl the medium to hasten the even distribution of
BrdU. Cover the plates LOOSELY with aluminum foil to block out ambient light and place
in the incubator.
The fifth plate from the expansion should remain in culture until it is 80%
confluent. It may be then be frozen. Alternatively, the fifth culture may be carried until
the procedure is complete and satisfactory results have been obtained, in order to avoid
the delay from having to thaw, grow, and split a new culture in the event of failure.
ARRESTING CELLS IN METAPHASE
Cells should be harvested after two rounds of cell division. Approximately 4
hours before harvest is scheduled, add Colcemid to 0.02 μg /mL final concentration and
swirl to distribute. This should be performed using asceptic technique in a laminar flow
hood, in the dark, as above. Replace the aluminum foil and return the plates to the
incubator. In general, about 5% of an actively dividing culture is in metaphase at any
given time. Colcemid works by inhibiting mitotic spindle formation, preventing cells
from segregating chromosomes. The prescribed concentration of Colcemid in the
medium is sufficient to arrest cells in metaphase and prevent them from continuing
through the cell cycle. The length of time in the presence of Colcemid allows for
enrichment of the percentage of the population of cells in metaphase by arresting and
accumulating cells as they reach metaphase. Adding a higher concentration of Colcemid
WILL NOT increase the number of cells in metaphase. The amount of time the cells are
left in Colcemid will influence the number of metaphases, however, and should be
adjusted depending on how quickly the cells divide. The longer the time in Colcemid, the
higher the percentage of cells in metaphase will be. However, if cells are arrested in
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metaphase by the Colcemid for too long, the chromosomes will condense and shrink
somewhat, rendering them suboptimal for staining and scoring later in the procedure.
We have found that for a cell line which doubles approximately every 24 hours, 4 hours
in Colcemid is sufficient for enriching the number of metaphases with minimal numbers
of shrunken chromosomes.
HARVESTING CELLS FOR METAPHASE
FOR ADHERENT CELLS: Remove cells from the incubator and aspirate medium as
usual. Add 2 mL 0.05% Trypsin/EDTA, wait for cells to detach fully, and harvest by
adding back complete medium followed by centrifugation to recover a cell pellet, as
usual. Note: Some investigators prefer to enrich for metaphase cells from adherent
cultures by using dilute trypsin/EDTA to slow the detachment process so that cells can
be recovered by agitation as they begin to ball up. Theoretically, the metaphase cells
will preferentially round up on the plate and become gently mechanically detachable
first, enabling non‐metaphase cells to be left behind. Many protocols include this step
for preferential harvest of cells in metaphase. We do not recommend this method, since
we find it difficult to perform reproducibly, and to generally result in a much smaller
yield without significantly increasing the proportion of metaphases. By this method, the
overall size of the pellet is reduced by 80% or 90%, and even though the pellet may
contain a much larger percentage of cells in metaphase, the pellet itself becomes
physically difficult to work with and is easily lost during repeated rinses in fixative
and/or dropping onto slides. By harvesting the entire plate, the non‐metaphase cells
add volume to the pellet, making it easy to work with. Using four confluent plates of
cells and a dense suspension eliminates the need for further metaphase enrichment by
preferential harvest.
FOR NON‐ADHERENT CELLS: No harvest with Trypsin/EDTA is necessary.
Centrifuge cell suspension to pellet and proceed with adding hypotonic solution as
described below.
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Aspirate medium. Gently flick the sides of the tube with your finger to
mechanically loosen the pellet and then add 1 mL hypotonic solution. Pipette up and
down gently with a P1000 pipetman to completely and homogenously resuspend the
pellet in the hypotonic solution.
Add 7 more mL hypotonic solution, mix by gentle inversion, and place in the
incubator for 12 minutes. The hypotonic solution causes water to diffuse into cells by
osmosis, making them swell. This change in morphology is visible under the microscope.
The amount of time is approximate. About 12 minutes is usually sufficient. Leaving the
cells in hypotonic solution for too long will cause delicate cells to lyse.
Add 2 mL freshly prepared 3:1 methanol/acetic acid fixative and invert the tube
a few times to mix and fully resuspend cells. If cells have lysed due to an overlong
exposure to hypotonic solution, it will be apparent at this time, since DNA released from
lysed cells will appear “gooey” and will not resuspend.
Centrifuge for 5 minutes at 200 x g to pellet the swollen, partially fixed cells.
Remove the hypotonic/methanol/acetic acid by aspiration, taking care not to aspirate
the pellet.
Add 5 mL of 3:1 methanol/acetic acid fixative and resuspend the pellet. Cells will
appear opaque white and the pellet will only require gentle inversion of the tube for
complete resuspension after this step. The protocol may be stopped at this point and
cells stored in the fixative solution at 4 C indefinitely.
PREPARING AND STORING SLIDES FOR METAPHASE SPREADS
We find that a very slight “roughening” and degreasing of the slide surface with
dilute HCl helps cells adhere better to the slide upon dropping. This process should be
completed the day before dropping to ensure that slides are completely chilled. Fill a
slide rack with new, dry microscope slides.
Completely immerse the slides in a solution of 0.1 N HCl in 95% EtOH at room
temperature for 20 minutes.
Remove the rack and completely immerse in a container filled with 95% EtOH.
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Remove the rack, dump the EtOH, replace with fresh 95% EtOH, and immerse slides.
Repeat for a total of three rinses in EtOH.
Follow with three rinses in fresh distilled H2O.
Store slides completely submerged in distilled H2O at 4 C. It takes several hours
for the water and slides to chill to 4 C. Although the process may be hastened by chilling
in a ‐20 C freezer, there is a risk for freezing, container breakage, and slide breakage. We
find it most convenient to prepare the slides at least a day in advance of dropping.
Unused slides can be stored indefinitely, submerged in distilled H20, at 4C.
MAKING METAPHASE SPREADS
Use 3:1 methanol/acetic acid fixative made fresh on the day that cells are to be
dropped onto the slides. According to some protocols this procedure works best on wet
days, when the room is air particularly humid due to the manner in which atmospheric
conditions affect the speed of evaporation of the fixative solution on a microscope slide.
We have not found normal room air humidity to be problematic. This procedure works
well at normal humidity, 28% to 35%. It does seem to work better, even on sunny days,
if the room temperature is slightly high, around 27 C.
Centrifuge swollen/fixed cells at 200 x g for 5 minutes, aspirate fixative,
resuspend in 5 mL fresh fixative.
Repeat for a total of three aspirate/resuspend/centrifuge cycles.
Resuspend cells in the minimal amount of fixative that causes the suspension to
have a slightly translucent, milky appearance similar to looking through Scotch tape.
Remove a slide from the container of chilled water. Prop one end on a
disposable 10 mL serological pipette so that it angles slightly downward.
Attach a rubber suction bulb to a 1 mL glass Pasteur pipette with a 5” barrel.
Insert the pipette into the cell suspension and squeeze the bulb to draw up the cells.
Position the end of the pipette about 5 inches above the slide and quickly distribute 7 to
10 drops of cell suspension along the length of the still‐wet slide. NOTE: These steps
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should be done as rapidly as possible, to ensure that the slide is still very wet with
distilled water when the cells are dropped onto it. It may be helpful to fill the pipette
with cell suspension and rest it in the centrifuge tube. Remove the slide from the H20
container with one hand and rest it on the serological pipette. IMMEDIATELY drop the
cells using the other hand.
Allow most of the liquid to pool at the bottom of the slide, and quickly follow
with 7 or 8 drops of 3:1 methanol/acetic acid fixative.
Once this has also pooled at the bottom of the slide, blot the excess liquid from
the bottom edge of the slide using a paper towel. Hold the slide about an inch from your
open mouth and exhale a single breath (don’t blow!), then fan the slide once back and
forth in the the air. Set the slide vertically upright at approximately 90 degrees to the
benchtop, leaning against a vertical surface (we use an empty test tube rack).
After about 30 seconds, pick up the slide and watch for the fixative to begin to recede
from around the edges of the slide as it evaporates. When this occurs, place the slide on
a slide warmer at 42 C and allow to completely dry. If the slides are too dry, the
chromosomes will be too close to each other to allow for appropriate staining and
scoring. If the slides are too wet, individual chromosomes will float away from one
another and not form obvious spreads which can be visualized in a single microscope
field.
Repeat this process to make several slides from the cell suspension. The cells will
settle relatively rapidly in the tube. Handle them carefully, inverting gently to remix.
Vigorous pipetting will cause cells to rupture while still in the tube.
Once slides are dry (about 10 minutes on the slide warmer at 42 C), metaphases can be
located using a 25X objective on the inverted microscope. The vast majority of cells will
be round and intact (predominantly non‐metaphase cells) but occasionally, there should
be easily visible, tiny, x‐shaped chromosomes arranged in small spreads. Screen each
slide to ensure that there are at least twenty or thirty metaphases. Allow slides to dry
overnight in the open air at room temperature on the benchtop.

31

DIFFERENTIAL SISTER CHROMATID STAINING WITH GIEMSA
Immerse slides with metaphases in 10 μg/ml (1/100th volume of 1 mg/mL stock)
Hoechst 33258 in water for 20 minutes. The Hoechst 33258 is a UV sensitizer.
Rinse by immersing slides in Sorensen’s buffer. Note: Some protocols call for using
McIlvaine’s buffer at this step, but in our hands, this solution tends to precipitate and
leave debris on the slide. We get acceptable quality results with the use of Sorensen’s
throughout the procedure.
Remove each slide from the rack, quickly pipette a few drops of Sorensen’s
buffer along the length of the slide, and immediately add a coverslip to prevent slides
from drying out. DO NOT SEAL THE COVERSLIP TO THE SLIDE.
Expose slides coverslip‐side‐up on a 55 C slide warmer to long wavelength
(approximately 365 nm) UV light (for example, at a distance of 5‐10 cm from two 20
watt blacklight‐blue bulbs) for 20‐30 minutes. Exposure to UV preferentially nicks DNA
with more highly incorporated BrdU, preventing it from accepting Giemsa stain later in
the procedure.
Carefully remove and discard the coverslips and place the slides back in an
empty rack. Immerse the rack in 1X SSC and incubate for 1 hour at 50 C. We use one of
the EasyDip containers immobilized in a shaker oven, but a regular hybridization oven or
warm room would work equally well.
Remove the slides from SSC and immerse the slides in 10% Giemsa made up in
Sorensen’s buffer for 30 minutes at room temperature.
Rinse by quickly immersing the slides in distilled H20 and allowing them to drain
on a paper towel. Two or three quick rinses in water may be required to remove the
Giemsa solution, although it is not necessary for all of the Giemsa stain to be completely
rinsed away. The slides will retain a purplish tint at the end of this procedure. Only rinse
the slides suffienciently to keep droplets of relatively concentrated Giemsa solution
from collecting and drying on the slide surface, which would obscure the results.
Allow the slides to dry face up without a coverslip on the benchtop overnight at
room temperature.
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PREPARING SLIDES FOR VISUALIZATION
Place one or two drops of Cytoseal‐60 low viscosity mounting medium onto slide
and add coverslip. Ideally, slides should be left face‐up overnight to allow the Cytoseal¬
60 to dry completely. Although the medium is characterized as fast‐drying, we have
experienced some difficulty with coverslip displacement when the slides were not
allowed to dry completely before microscopy.
VISUALIZING AND DIGITAL IMAGING OF CHROMOSOMES
Observe SCE's using brightfield microscopy and a 63x or 100x high‐quality oil‐
immersion objective lens. A microscope with good optics is absolutely required. At a
minimum, a 63x plan apochromatic oil‐immersion objective lens with a numerical
aperture of 1.4 is necessary. Otherwise, the differentially stained sister chromatids will
fail to resolve, and the lighter staining chromatid will appear washed out to the point of
invisibility. This assay is impossible with inferior quality optics. High‐quality digital
imaging equipment and interface is also essential for effective and efficient data
acquisition. Adjust the exposure and gain settings to capture as optimal an image as
possible. Use the microscope/camera’s imaging software and manufacturer’s
instructions to save captured images as TIFFor high‐quality JPEG files. Images may be
saved as grayscale.
After capture and saving, open the image in image processing software such as
Adobe Photoshop or Macintosh Preview and adjust the magnification, contrast , and
grayscale levels to maximize the differential staining of the sister chromatids.
SCORING SISTER CHROMATID EXCHANGES AND ANALYZING DATA
Well‐stained metaphase spreads are straightforward to score for sister
chromatid exchanges. It is convenient to print a high‐resolution hardcopy of the image
file and score the number of exchanges and chromosomes on the paper printout, then
input the numbers into a spreadsheet program such as Microsoft EXCEL. A properly
differentially stained chromatid pair with no SCEs will appear as one black stripe (the

33

mono‐strand BrdU‐substituted sister) and one lighter gray stripe (the doubly
BrdU¬substituted sister). A single exchange is any time the dark and light staining on the
chromatids switches places. The BrdU itself induces a low level of SCEs so it is rare to
find an entire spread with no exchanges whatsoever. Count the total number of
exchanges in the spread and also the total number of scorable chromosomes in a
spread. If the change happens at the centromere, this may be due to the chromosome
being twisted and does not represent a true sister chromatid exchange. Do not include
these chromosomes. If the image is ambiguous and it is not possible to determine with
reasonable certainty that an exchange has taken place (i.e. partially stained
chromosome) do not include that chromosome in the count. Even very small
chromosomes, if they show two distinctly differentially stained chromatids, should be
included in the score. For each metaphase spread, divide the number of exchanges by
the total number of scorable chromosomes in the spread. This is the number of
exchanges per chromosome. Scoring 20 metaphases should provide a general idea of
the level of stability. If there is a great deal of variability between the scores of each
spread, 50 or even 100 metaphases may be required to provide adequate statistical
power when assessing SCE differences between varying experimental conditions.
3.5: NOTES, TIPS, AND TROUBLESHOOTING
For non‐adherent cells, omit the trypsin/EDTA steps entirely. Use 6‐well plates or
tissue culture flasks for growing non‐adherent cells and establishing doubling time. Add
BrdU and Colcemid per protocol, then centrifuge the entire culture, aspirate medium,
and replace with hypotonic solution. Continue protocol steps as described.
Depending on membrane characteristics, some cell lines are more amenable to
this procedure than others. It may be useful to practice making metaphase spreads
using HeLa or K562 cells first.
If only one chromatid is visible after staining or if chromosomes appear
extremely dessicated, try decreasing the UV exposure time. Overexposure to UV will
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essentially obliterate the sister which contains BrdU, and render it invisible, rather than
very lightly stained.
If both chromatids appear lightly stained, but there is no differentiation, or if
there is only partial staining of one chromatid, decrease the amount of time between
adding BrdU and harvest. Allowing more than two rounds of division in the presence of
BrdU will cause incorporation into both of the sisters, preventing differential staining.
If both chromatids appear darkly stained, try increasing the time between adding
BrdU and harvesting. Insufficient incorporation of BrdU will cause the sisters to accept
Giemsa equally well, resulting in no differential staining.
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FIGURE 3.1: BRDU INCORPORATION FOR FPG STAINING OF SISTER CHROMATIDS

BLUE: Unsubstituted DNA strand. PINK: BrdU‐substituted DNA strand
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FIGURE 3.2: DIFFERENTIALLY STAINED SISTER CHROMATIDS IN A METAPHASE SPREAD

RED CIRCLES: True sister chromatid exchanges
BLUE CIRCLE: Change at the centromere. Not definitively arisen by SCE. Possibly
chromosome is flipped at centromere. Changes at the centromere should not be
scored.
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CHAPTER 4: GENOMIC ARCHITECTURE AND INHERITANCE OF HUMAN RIBOSOMAL
GENE CLUSTERS *
*This chapter has been published: Genome Res. 2008 January; 18(1): 13–18.
doi: 10.1101/gr.6858507.
4.1: SYNOPSIS
The finishing of the Human Genome Project largely completed the detailing of
human euchromatic sequences. However, the most highly repetitive regions of the
genome still could not be assembled. The twelve gene clusters which generate the
structural RNA components of the ribosome are critically important for cellular viability,
yet fall into this unassembled region of the Human Genome Project. To determine the
extent of human variation in ribosomal RNA gene content (rDNA), and patterns of rDNA
cluster inheritance, we have determined the physical lengths of the rDNA clusters in
peripheral blood white cells of healthy human volunteers. The cluster lengths exhibit
striking variability between and within human individuals, ranging from 50 kilobase pairs
(kbp) to over 6 megabase pairs (Mbp), manifest essentially complete heterozygosity,
and provide each person with their own unique rDNA electrophoretic karyotype.
Analysis of these rDNA fingerprints in multi‐generational human families demonstrates
the rDNA clusters are subject to meiotic rearrangement at a frequency greater than 10%
per cluster, per meiosis. With this high intrinsic recombinational instability, the rDNA
clusters may serve as a unique paradigm of potential human genomic plasticity.
4.2: INTRODUCTION
Each human ribosome contains four RNA molecules (rRNA) that play
indispensable roles in all protein translation. In order to produce sufficient rRNA for the
highly abundant ribosomes, the genes encoding the rRNA are represented genomically
in multiple copies. The 5S rRNA molecule (OMIM 180420) is produced from a cluster of
repeated 2.2 kbp genes [Little RD and Braaten DC 1989; Sorensen PD and Frederiksen S
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1991] on maternal and paternal chromosome 1q42 [Sorensen S et al 1991]. Similarly,
the remaining three rRNA molecules, 18S, 5.8S and 28S, are produced by
post¬transcriptional processing of a 45S precursor transcript expressed from clusters of
repeated 43 kbp genes [Gonzalez LL and Sylvester JF 1995] on maternal and paternal
13p12, 14p12, 15p12, 21p12 and 22p12 [Henderson AS et al 1972] (OMIM 180450 –
180454). Overall, the rDNA clusters consist of repeated individual rRNA genes abutting
each other in a largely head‐to‐tail orientation, devoid of intervening non‐rDNA
sequences [Caburet S et al 2005; Little RD and Braaten DC 1989; Schofer C et al 1998;
Shiels C et al 1997; Sorensen PD and Frederiksen S 1991].
The repetitive, clustered nature of the rDNA was noted in early quantitative
hybridization studies [Schmickel RD and Knoller M 1977], and lead to the hypothesis
that, “the number of rRNA genes, although a polymorphic character, is an inheritable
attribute of [a] given nucleolar organizer.” [Guanti G and Petrinelli P 1974] This
prediction was supported by tracking patterns of silver‐stained acrocentric
chromosomes in human families [Markovic, VD et al 1978; Taylor EF and Martin‐DeLeon
PA 1981], although the stain was noted to be a function of both rDNA quantity and
transcriptional activity [Miller DA et al 1976]. Through analysis of sequence
polymorphisms within individual rDNA repeat units, it was determined that there was
strong recombination activity both intra‐and interchromosomally within the rDNA,
leading to concerted evolution of rDNA sequences and clusters [Arnheim N et al 1980;
Gonzalez LL and Sylvester JE 2001; Kuick R et al 1996; Worton, RG et al 1988].
Nevertheless, direct biochemical evidence of meiotic rDNA cluster recombination and
quantitation of rDNA within individual rDNA clusters has proven elusive. We present
here the determination of individual rDNA cluster lengths, the corresponding degree of
person‐to‐person variability, and patterns of meiotic rDNA cluster inheritance and
recombination.
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4.3: RESULTS
Our experimental approach is shown in Figure 4.1. Very high molecular weight
genomic DNA is prepared from human peripheral blood [Birren B and Lai E 1993], and
intact rDNA clusters are released from the bulk genomic DNA by restriction digestion.
Since the individual rRNA genes are very highly self‐similar [Gonzalez IL and Sylvester JE
2001; Sorensen PD et al 1990], liberating intact rDNA gene clusters is feasible, as a
restriction enzyme without a recognition site in a single rDNA gene will typically lack a
recognition site throughout the entire cluster. The intact clusters are separated by size
in a pulsed field gel, and detected by hybridization with either a 5S or 45S rDNAspecific
radiolabeled probe.
5S rDNA clusters (Fig. 4.2A) isolated from anonymous human blood donors
demonstrate tremendous allelic diversity, with most of the donors showing two distinct
5S rDNA cluster lengths that clearly indicate differentially‐sized 5S rDNA clusters
between maternal and paternal 1q42. Indeed, we have yet to observe a person
homozygous for 5S rDNA cluster lengths. Occasionally, as seen in donor #10, we resolve
three 5S rDNA bands; the presence of an extra band is enzyme specific, and we infer
that a chance polymorphism in one of the 5S repeats has coincidentally created this
specific restriction site within the gene cluster.
The Human Genome Project [Consortium 2004] (build 36.2) shows 17.2 5S rDNA
repeats on 1q42 with an overall sequence conservation of 99.6% [Clamp M et al 2004].
The Genome Project and other sources [Little RD and Braaten DC 1989; Sorensen PD
and Frederiksen S 1991] give a unit 5S rDNA repeat length of 2236 base pairs. Using our
5S rDNA cluster length data and the lengths of the unit 5S rDNA repeat and non‐rDNA
flanking sequences [Consortium 2004], we directly calculated the number of human 5S
rDNA repeats (Table 1) in a total of 27 human donors (18 shown in Fig. 4.2A and nine
additional unrelated individuals from Fig. 4.3A). Our average 5S rDNA cluster length of
98 repeats is consistent with earlier hybridization studies [Sorensen PD and Frederiksen
S 1991], however, the Human Genome Project's total of 17.2 repeats is over 2.3
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standard deviations outside this value, likely as a result of the difficulty the Genome
Project has in correctly assembling very highly
self‐similar sequences [She X et al 2004].
45S rDNA cluster lengths from the same anonymous donors (Fig. 4.2B) also
exhibit striking person‐to‐person variability. Consistent with 45S clusters on the five
pairs of human acrocentric chromosomes, our pulsed‐field gel analysis revealed 8 to 10
bands per person. We assume that individuals showing less than 10 bands have yet
additional bands larger than 10 Mbp that are incapable of entering a pulsed‐field gel
[Birren R and Lai E 1993], although complete loss of rDNA sequences on specific
acrocentric chromosomes is an alternative possibility. The 45S rDNA cluster size
variation is consistent with our 5S rDNA cluster data: the 45S rDNA clusters display
distinct and independent size variation on parentally homologous chromosomes. The
45S rDNA clusters shown here range in length from approximately 70 kbp to over 6
Mbp. For a unit 45S rDNA repeat size of 43 kbp [Gonzalez IL and Sylvester JE 1995],
these data indicate cluster sizes from a single 45S rDNA unit alone up to over 140
repeats. While the lack of resolution above 6 megabases precludes an exact
determination of human total diploid 45S rDNA content, our results are consistent with
the upper range of earlier hybridization experiments of approximately 600 copies per
diploid human cell [Schmickel RD 1973]. In contrast to the 5S rDNA clusters on 1q42,
there are currently no data from the Human Genome Project concerning 45S rDNA
cluster lengths.
Beyond variation in cluster length between individuals, we observed other
intriguing features of 5S and 45S rDNA architecture, including evidence of significant
meiotic rearrangement. In our analysis of the 5S rDNA clusters from four different
human families (Fig. 4.3B), it can be seen that the paternal 5S rDNA cluster of PYFI‐02B
was inherited with a meiotic rearrangement. We verified the presence of this de novo
5S rDNA cluster length, relative to the 5S clusters in PYFI‐02B's parents PYFI‐10 and
PYFI¬20, with a panel of three different restriction enzymes (Fig. 4.3B). Commercial
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short tandem repeat (STR) testing verified that PYFI‐20 is indeed the biological father of
PYFI¬02B.
The higher resolution of the 5S rDNA clusters in Fig. 3b also revealed an
additional faint band in PYFI‐02B of intermediate length at approximately 2% of the
intensity of the two major 5S rDNA cluster bands for this individual. The intensity of the
bands is directly proportional to both the cluster length and the percentage of cells in
the sample harboring a particular 5S rDNA cluster in these experiments. Therefore, we
interpret this fainter band to be the product of a somatic recombination event occurring
in the hematopoietic stem cell population during the embryogenesis of PYFI‐02B,
making the peripheral blood of PYFI02B genetically mosaic for the 5S rDNA clusters.
Given that three distinct restriction enzymes yielded the same banding pattern, we can
rule out the possibility of partial digestion as a source of this band.
The 45S rDNA clusters display an even larger degree of both meiotic
rearrangement and somatic mosaicism (Fig. 4.4A). There are clear examples of inherited
rearrangement in five of the offspring (ARDO‐10, PYFI‐02B, VAGR02A, VAGR¬02B, and
THAE‐02), as indicated by the bands enclosed in dotted circles. For example, VAGR‐02B
possesses a cluster of 4.6 Mbp that is 1.6 Mbp larger than the largest cluster from either
his mother (VAGR‐10) or father (VAGR‐20). A similar expansion is observed in the 6 Mbp
cluster of PYFI‐02B that is at least 0.5 Mbp larger than the largest rDNA cluster in either
of his parents. Since clusters of repeated genes are potentially susceptible to
recombinational erosion by single strand annealing [Stark JM et al 2004), the ability to
extend the cluster lengths through meiotic recombination may be evolutionarily
important for maintaining a steady‐state level of rRNA genes.
A high‐resolution gel for the 45S rDNA clusters smaller than 1 Mbp in size (Fig.
4.4B) provides a superior view of this meiotic rearrangement. VAGR‐02A has clusters of
625 kbp and 715 kbp (dotted circles) that are not found in either his mother (VAGR‐10)
or father (VAGR‐20). Likewise, the 950 kbp cluster found in THAE‐02 is not found in
either of his parents (THAE‐10 and THAE‐20). Collectively, we observe 11 clear examples
of 5S or 45S rDNA cluster meiotic restructuring in 5 of the 8 parent‐child trios analyzed.
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Similar to the 5S rDNA cluster analysis of PYFI‐02B (Fig. 4.3B), minor bands
arising from 45S rDNA cluster somatic mosaicism are also apparent (Fig. 4.4B). PYFI‐10
shows the strongest minor banding with a 910 kbp length cluster at approximately 25%
of the intensity of her major 45S rDNA bands in that size range. The VAGR‐02A,
VAGR¬20, THAE‐10, and THAE‐02 lanes all possess minor bands ranging from 5% to 10%
the intensity of their respective major banding patterns. It is possible the minor band in
THAE‐10 at 4.3 Mbp represents a 45S rDNA mosaicism that exists in some fraction of her
germline, such that her son THAE‐02 inherited this cluster in Mendelian fashion from
her. In total, we can detect minor‐intensity mosaic banding patterns in about 1/3 of the
individuals tested.
4.4: DISCUSSION
Collectively, we observed one occurrence of 5S and ten occurrences of 45S rDNA
gene cluster meiotic restructuring in 5 of 8 parent‐child trios analyzed, for a total of 11
clearly identifiable events. Given a potential total of 96 different rDNA clusters (8
children, each with two 5S and up to ten 45S rDNA clusters), this yields an average
recombination rate of 11% per generation per gene cluster (95% confidence interval
[Agresti A and Coull BA 1998): 6.4% to 20%). This rapid meiotic restructuring likely
accounts for the present‐day inter‐person variability in both rDNA quantity and genomic
organization. We cannot currently ascertain the relative degree to which this diversity is
generated by recombination between rDNA clusters on non‐homologous chromosomes,
parental homologs or sister chromatids, although familial analysis of flow‐sorted
acrocentric chromosomes may be able to answer this question.
Molecular combing experiments indicate that the rDNA clusters largely consist of
repeats oriented in a head‐to‐tail configuration, but also with a substantial fraction of
individual repeats within any given rDNA cluster in the inverted or palindromic
orientation [Caburet S et al 2005]. Intermolecular recombination between such inverted
rDNA repeats would generate a dicentric chromosomal translocation product linked by
an rDNA cluster, reminiscent of the Robertsonian translocations between the various
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acrocentric chromosomes frequently observed in the human population. Actual
Robertsonian translocations, however, almost invariably have fusion breakpoints not in
the rDNA, but rather in satellite III DNA proximal to the centromere, with resulting
complete loss of rDNA sequences [Page SL et al 1996; Sullivan BA et al 1996], and this is
also true for dup(21q) chromosomes that account for 2% of Down syndrome patients
[Antonarakis SE et al 1990]. Although there are scattered examples [Boyd LJ et al 2005],
why rDNA recombination mediated acrocentric chromosome fusions are generally not
observed is unclear. Conceivably, the greater distance between centromeres in such an
rDNA acrocentric fusion, relative to the smaller inter‐centromeric distance of satellite III
fused Robertsonians, would allow both centromeres to retain activity and lead to fusion
chromosome loss, whereas inactivation of one of the two Robertsonian centromeres
allows stable chromosomal transmission [Page SL and Shaffer LG 1998].
The human 5S and 45S rDNA gene clusters are clearly capable of very rapid copy
number evolution. Although there may be considerable flexibility in rRNA expression at
the transcriptional level via epigenetic control [Kawasaki K et al 1992; Maye C et al
2006), for long‐term maintenance of population equilibrium rDNA levels there must be
underlying evolutionary pressures constraining the total rDNA copy number between
specific minimum and maximum values. It is not intuitively obvious what the phenotype
of an rDNA deficiency would be. Chicken strains in which rDNA levels are reduced to
56% of wild‐type levels are viable [Delany, ME et al 1995], however, a reduction to 45%
of wild‐type rDNA levels results in teratogenic embryonic failure [Delany ME et al 1994].
We suggest that in humans, a partial rDNA insufficiency may manifest as bone marrow
failure, similar [Ellis SR and Massey AT 2006] to the way in which ribosomal protein
haploinsufficiency can cause Diamond‐Blackfan anemia [Draptchinskaia N et al 2006].
We anticipate that further study of the rDNA gene clusters, which are fundamentally
required for cellular metabolism yet are highly variable in copy number and exhibit
significant instability, will provide further insight into the role of copy number variation
in human genomic architecture and stability.
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4.5: METHODS
High molecular weight genomic DNA was prepared in agarose from peripheral
blood via ammonium chloride erythrocyte lysis (generally according to methods
described in Birren and Lai [Birren B and Lai E 1993]) with a final concentration of 1x107
white blood cells per ml of 0.8% low‐melting temperature agarose. Agarose/DNA slices
of approximately 15 µl volume were digested with 50 units of indicated restriction
enzymes (New England Biolabs) overnight at 37C and subsequently sealed with low
melting temperature agarose into gels for electrophoresis. All electrophoresis was
performed using a CHEF Mapper® (Bio‐Rad) system. Gels were subsequently processed
according to Lueders and Fewell [Lueders KKI and Fewell JW 1994] and Ehtesham and
Hasnain [Ehtesham NZ and Hasnain SE 1991] with minor modifications.
Hybridization probes:
5S rDNA: Human genomic DNA was PCR amplified using primers:
5'¬gggctcgaggacaaaagtagcgcgaggtc and 5'‐gggtctagacagccaccgggaaaacag yielding a 489
bp fragment. 45S rDNA: Human genomic DNA was PCR amplified using primers:
5’¬gggctcgagatttgggacgtcagcttctg and 5'‐gggtctagagtgctcccttcctctgtgag yielding a 532 bp
fragment.
PCR products were subsequently digested with XhoI and XbaI, subcloned
individually into pBluescript II SK‐(Stratagene) and verified by DNA sequencing. XhoI /
XbaI fragments from these plasmids were 32P radiolabeled using a Prime‐It II kit
(Stratagene).
Pulsed field gels:
Figure 4.2A: Genomic DNA digested with EcoRV. 1% Pulse Field Certified (PFC)
agarose (Bio‐Rad), 0.5x TBE (44.5 mM tris, 44.5 mM borate, 1 mM EDTA pH 8.0), 14C, 6
V/cm, 120º included angle, 3‐90 second field switching with linear ramp, 24 hours total
electrophoresis.
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Figure 4.2B and 4.4A: Genomic DNA digested with EcoRV. 1% SeaKem Gold
agarose (Cambrex), 1x TAE (40 mM tris, 40 mM acetate, 1 mM EDTA pH 8.0), 14C, 2
V/cm, 106º included angle, 5‐40 minute field switching with linear ramp, 92 hours total
electrophoresis.
Figure 4.3A: Genomic DNA digested with HindIII. 1% PFC agarose (Bio‐Rad), 0.5x
TBE, 14C, 6 V/cm, 120º included angle, 10‐40 second field switching with linear ramp, 20
hours total electrophoresis.
Figure 4.3B: 1% PFC agarose, 0.5x TBE, 14C, 6 V/cm, sequence of electric field
vectors relative to 0º as "forward": ‐60º, 180º, +60º, ‐60º, +60º, 180º, ‐60º, +60º, field
durations: ±60º field vectors: 10 seconds, 180º field vectors: 5 seconds, 42 hours total
electrophoresis. Pulse field parameters adapted from Clark et al. [Clark SM et al 1988].
Figure 4.3b: as Figure for Figure 4.2A, except using a "ramp factor" (Bio‐Rad) of
0.357.
Gel post‐electrophoresis processing and hybridization:
Gels were equilibrated to a final concentration of 0.5% glycerol in water, dried at
65C and subsequently rehydrated with two exchanges of distilled water. Rehydrated
gels were denatured with 0.4N NaOH / 0.8 M NaCl followed by neutralization in 0.5 M
Tris pH 8.0 / 0.8 M NaCl. Gels were pre‐hybridized in 2x SSC / 7% SDS / 0.5% casein at
65C and then hybridized to radiolabeled probe sequences overnight at 65C in fresh pre‐
hybridization solution. Gels were rinsed at 65C with 2x SSC / 0.1% SDS for 30 minutes
and then again with fresh solution for 60 minutes. Gels were then rinsed at 65C twice
with 0.5x SSC / 0.1% SDS for two hours per rinse. Gels were finally rinsed briefly with 2x
SSC at room temperature and imaged using a PhorphorImager® system (Molecular
Dynamics).
Commercial STR allele testing: Dried blood spotted on FTA Micro Cards
(Whatman) was analyzed by The Genetic Testing Laboratories, Inc. (GTL), 3655 Research
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Drive, Las Cruces, NM 88003. We use simplified identifying labels for the PYFI family in
the main text.
Human Subjects: All human subjects protocols were reviewed and approved by
the Institutional Review Board of the University of Kentucky
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FIGURE 4.1: EXPERIMENTAL STRATEGY

Release of intact rDNA clusters from bulk genomic DNA. (Open rectangles)
Individual rDNA repeat units; (double line) non‐rDNA genomic DNA; (arrows)
hypothetical restriction sites.

TABLE 4.1: HUMAN 5S RIBOSOMAL REPEATS (27 DONORS)
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FIGURE 4.2: NORMAL HUMAN RDNA CLUSTER LENGTH VARIABILITY

Eighteen healthy anonymous human donors are shown. (A) 5S rDNA gene clusters. (B)
45S rDNA gene clusters. Cluster lengths are based upon chromosome size standards
from S. pombe, H. wingei and lambda phage concatemers wingei and S. cerevisiae and
lambda phage concatemers
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FIGURE 4.3: GENOMIC ARCHITECTURE AND PATTERNS OF HUAN INHERITANCE OF 5S
RIBOSOMAL DNA

A) Four families, “ARDO,” “PYFI,” “VAGR,” and “THAE” are shown. Relationship codes:
(01) daughter, (02) son, (10) mother, (20) father, (40) maternal grandmother, (60)
paternal grandmother, (70) paternal grandfather. Siblings of the same sex and
generation are additionally designated “A,” “B,” in descending birth order. (Dotted
oval) A band not represented in either parent. rDNA cluster lengths are measured in
kilobases and calibrated using lambda phage concatemers. (B) PYFI family 5S rDNA
structure at high resolution and contrast. Restriction enzymes used to liberate 5S gene
clusters from bulk genomic DNA are shown above sets of family samples. (Dotted
ovals) Bands not represented in either parent. (Square brackets) Bands of
nonstoichiometric signal intensity. (Left) Lambda phage concatemer size references:
λ3 = 145,506 bp, λ4 = 194,008 bp, λ5 = 242,510 bp.
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FIGURE 4.4: GENOMI ARCHITECTURE AND PATTERNS OF HUMAN INHERITANCE OF 45S
RIBOSOMAL DNA

(A) Four families, “ARDO,” “PYFI,” “VAGR,” and “THAE” are shown. Relationship
codes: (01) daughter, (02) son, (10) mother, (20) father, (40) maternal grandmother,
(60) paternal grandmother, (70) paternal grandfather. Siblings of the same sex and
generation are additionally designated “A,” “B” in descending birth order. (Dotted
ovals) Bands not represented in either parent. (Square brackets) Bands of non‐
stoichiometric signal intensity. Cluster lengths are calibrated on chromosomal size
standards from S. pombe, H. wingei, and S. cerevisiae and lambda phage
concatemers.(B) High resolution. Note resolution of two bands at 600–700 kb in
VAGR‐02A with respect to the unresolved doublet in this size range in panel A.
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CHAPTER 5: RECOMBINATION PHENOTYPES OF THE NCI‐60 COLLECTION OF HUMAN
CANCER CELLS
5.1: SYNOPSOS
Double strand breaks which arise during the S or G2 phase of the cell cycle are
generally repaired by homologous recombination, which occasionally results in crossing
over and the physical exchange of DNA between sister chromatids. Genes arranged in
clusters of repeats are subject to structural rearrangement via this mechanism, as their
size and extreme sequence identity generate the potential for exchange between
misaligned repeats in a process known as non‐allelic homologous recombination.
Dysregulated homologous recombination is believed to be one mechanism of genome
destabilization by which cancer cells may acquire selective advantage. The sister
chromatid exchange assay is a well known technique for visualizing large‐scale
chromosomal rearrangements which arise by homologous recombination but cannot
measure rearrangement at the submicroscopic level, where non‐allelic homologous
recombination occurs. We have developed an assay to measure structural instability in
gene clusters, and have shown that the ribosomal RNA gene clusters demonstrate
marked instability in human solid tumors. This work represents our use of the
extensively characterized NCI‐60 panel of human cancer cell lines to determine whether
gene cluster instability assay correlates with the sister‐chromatid exchange assay to
reflect genomic instability arising from dysregulated homologous recombination.
5.2: INTRODUCTION
Genomic instability is a fundamental characteristic of most solid tumors and
adult leukemias. The term encompasses a broad range of defects which arise by a
variety of damaging events and/or mechanistic failures of individual DNA repair
pathways. Whatever its source, genomic destabilization is believed to begin early in
tumor progression, creating heterogeneity within a population of cells, and conferring,
in concert with other events, a selective advantage to a given cell which dominates in
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proliferation [Anderson GR 2001; Stoler DL et al 1999]. Instability may or may not
continue as the tumor progresses. One means of genomic destabilization is defective or
dysregulated homologous recombination.
Homologous recombination (HR) is a mechanism for repairing double‐strand
breaks (DSBs) during S and G2 phase of the cell cycle. In contrast to non‐homologous
end joining (NHEJ), which results in a loss of genetic material, homologous
recombination is considered error‐free repair because it uses the available, identical
sequence from the sister chromatid to repair the DSB. Although NHEJ is capable of
repairing frank DSBs during G2/M, HR is preferred, especially for repairing the DSBs that
arise at stalled replication forks, for example from forks that encounter single strand
breaks or cross‐links [Rothkamm K et al 2003]. Mitotic HR is a complex, varied, and
tightly regulated process, and defects in several of the components of HR have long
been associated with cancer (reviewed in [Helleday T 2010;Reliene R et al 2007 ]). One
study shows overexpression of several HR‐associated genes in patients with non‐small
cell lung cancer [Saviozzi S et al, 2009]. Approximately 5% of the human genome is
comprised of large repetitive elements called low copy repeats (LCRs), also known as
segmental duplications, which possess sufficiently high sequence identity to cause
structural genomic instability via non‐allelic homologous recombination (NAHR)
between regions of identical sequence but differing genomic context, resulting in
insertions, deletions, and translocations ([Consortium IHG, 2004], reviewed in [Gu et al
2008]).
The most established means of detecting dysregulated homologous
recombination, whether in cells with defective/deficient HR capacity, or in response to
damage, is the sister chromatid exchange assay (SCE) that differentially stains sister
chromatids, allowing for microscopic detection of the physical exchange of DNA which
occurs with cross‐over HR [Wilson DM and Thompson LH, 2007]. The SCE assay has
been in use since the 1970s for the purpose of identifying potential “chromosomal
mutagenicity” of chemical agents [Perry P and Evans HJ 1975]. Chemicals that generate
cross‐linking of DNA are potent inducers of SCE, since HR is required to repair the
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resultant blockage during replication [Thompson LH 2005 ]. Conditions and drugs which
increase the number of single‐strand breaks (SSBs) also increase the number of SCEs,
presumably by overburdening the base‐excision repair (BER) pathway such that
unrepaired SSBs remain, become DSBs during replication, and must be repaired by
homologous recombination [Wilson DM and Thompson LH 2007]. HeLa cells with
downregulated XRCC1, a key component in the base excision repair pathway, show a
1.7‐fold increase in SCEs, and an almost 2‐fold increase when methyl methansulfonate
(MMS), a DNA methylating agent, is added [Fan J et al 2007]. Likewise, the thymidine
analog 5‐hydroxymethyl‐2'‐deoxyuridine (hmdUrd) at a 1 µM dose induces sister
chromatid exchanges resulting in a 6‐fold increase over background in Chinese hamster
ovary (CHO) cells [Kaufman ER 1989], presumably through stimulation of BER activity.
Inhibition or deficiency of poly(ADP‐ribose) polymerase (PARP) also increases levels of
sister chromatid exchange [Schultz N et al 2003]. Essentially, the HR pathway
compensates at least partially, for the defects or inadequacy of the BER response. PARP
inhibitors can induce synthetic lethality in cells with mutations in BRCA‐1 or BRCA‐2,
which are components of the HR pathway [Ashworth A 2008 ;Kyle S et al 2008].
Similarly, hmdUrd (or 5‐chloro‐2'‐deoxyuridine) exposure is synthetically lethal with loss
of key BER components such as XRCC1 [Horton JK et al 2008].
Despite the striking visible result upon staining, sister chromatid exchange is
genetically silent. It represents a very large scale physical relocation of genetic material
which is the consequence of a cross‐over recombination event; but there is no gain or
loss of genetic information between two identical sisters. Presumably, these cross‐overs
happen at the submicroscopic level as well, which is where true genomic destabilization
occurs. Our lab has developed an assay which measures non‐silent, molecular level
changes to genomic architecture by monitoring the stability of the length of gene
clusters or tandemly repeated segmental duplications which are the result of NAHR
[Killen MW et al 2009]. For this gene cluster instability (GCI) assay, we use the gene
clusters which encode the 45S precursor transcript to the 18S, 5.8S and 28S ribosomal
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RNA molecules. These clusters of tandemly repeated genes are divided amongst the five
acrocentric chromosomes, generating approximately 600 copies of the 43kb unit gene
[Henderson AS et al 1972]. We characterized the lengths of these rDNA gene clusters
from healthy blood donors and found complete heterozygosity on each of the five
chromosomes, and between the parental pairs of homologs. We also detected
abundant evidence of both human meiotic [Stults DM et al 2008] and mitotic
rearrangement [Killen MW 2009]. We recently used the GCI assay to compare matched
normal tissue to tumor tissue in patients with lung or colorectal cancer and found that
approximately 50% of the tumors show changes in the sizes of the clusters compared to
the normal tissue, as well as evidence of ongoing instability and heterogeneity within
the tumor population indicating that HR has at some point become dysregulated within
the tumor cells [Stults DM et al 2009]. Notably, loss or knockdown of the RecQ homolog
defective in Bloom syndrome (BLM) causes a remarkable 100x increase in rDNA gene
cluster instability rates along with the well‐characterized 10‐fold elevation in rates of
sister‐chromatid exchange in these cells [Chaganti RS 1974], suggesting elevated HR
with crossing‐over as the most likely mechanism [Wu L and Hickson ID 2003] for this
destabilization. Cells with defects in either of two other disease‐associated human RecQ
homologs, Rothmund‐Thompson syndrome protein (RTS) and Werner syndrome protein
(WRN), did not show destabilization by either assay, nor did wild‐type fibroblasts ([Killen
MW 2009] and our unpublished results). We also demonstrated that loss of the
ataxia¬telangiectasia‐mutated (ATM) protein causes a 10x elevation in rDNA GCI
instability, even though loss of ATM in the absence of exogenous DNA damaging agents
does not increase levels of sister chromatid exchange [White JS et al 2010; Bartram CR
1976; Galloway SM and Evans HJ, 1975].
We are interested in the manner by which elevated and/or dysregulated
recombination may be involved in the etiology of cancer and the development of
chemotherapeutic resistance. We reasoned that elevated recombination could be
caused either by an increase in recombination initiating lesions as the result of BER
deficiency as seen in XRCC1 mutants, or by alterations in the downstream biochemistry
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of recombination causing an increase cross‐over vs. non‐crossover recombination as
seen in BLM mutants. Accordingly, we screened the NCI‐60 panel of human cancer cell
lines for defective BER by sensitivity to hmdUrd, and for altered recombination
outcomes by the gene cluster instability assay. Lines exhibiting either phenotype were
subsequently characterized by sister chromatid exchange in order to cross‐compare
three potential mitotic recombination indicators.
5.3: MATERIALS AND METHODS
Cell culture
NCI‐60 cell lines were acquired frozen from the National Cancer Institute’s
Developmental Therapeutics Program, thawed and grown overnight in RPMI‐1640
culture medium supplemented with pen/strep/L‐glutamine solution and 10% fetal
bovine serum. The following day, the medium was replaced with RPMI‐1640 culture
medium with pen/strep/L‐glutamine solution and 5% fetal bovine serum. Cells were
maintained in this medium, at 37° C, in 5% CO2, in a humidified incubator for the
duration of these experiments.
High molecular weight DNA isolation
After harvest with 0.025% trypsin (adherent cells only), all cells were quantified
using a Partec benchtop flow cytometer. Single cell suspensions were adjusted to 1x107
cells/mL in low melting point agarose, drawn into a 1‐mL syringe, and chilled on ice until
solid phase. High molecular weight DNA was prepared from the solid‐phase agarose cell
suspension by means of digestion with 1% sarkosyl/500 mmol/L EDTA/0.5 mg/mL
proteinase K solution at 50° C for at least 16 h, after which it was treated with
phenylmethylsulfonyl fluoride in 10 mmol/L Tris/1 mmol/L EDTA (TE), extensively rinsed
in TE/50% glycerol, and stored at ‐20° C.
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Gene cluster instability analysis
The rRNA gene clusters were analyzed by pulse field gel electrophoresis and Southern
blotting essentially as described [Stults DM et al 2008]. Briefly, approximately 1 µg of
genomic DNA in solid phase was equilibrated in 1X NEBuffer 3 (100 mM NaCl;
50 mM Tris‐HCl; 10 mM MgCl2; 1 mM Dithiothreitol pH 7.9 @ 25°C) and digested with
EcoRV (New England Biolabs) overnight at 37° C to release intact gene clusters from bulk
genomic DNA. Digested DNA was placed into wells of a 1% Pulse Field Certified (Bio‐Rad)
agarose in 0.5X TBE (44.5 mmol/LTris /44.5 mmol/L boric acid/1.0 mmol/L EDTA pH 8)
gel and sealed using low‐melting‐point agarose. Gels were run using a CHEF‐MAPPER
(Bio‐Rad), adjusting parameters and settings according to desired size resolution.
Following electrophoresis, gels were equilibrated in glycerol and dried at 65° C. Dried
gels were rehydrated and the DNA was denatured using 0.4 N NaOH/ 0.8 mol/L NaCl
solution, neutralized in 0.5 mol/L Tris pH 8/0.8 mol/L NaCl, then prehybridized at 65 C in
hybridization buffer of 2X SSC (300 mmol/L NaCl/30 mmol/L Na‐citrate) with 7% SDS and
0.5% casein. Gels were probed in fresh hybridization buffer with an rDNA‐specific,
32P¬labeled probe (radiolabeled PCR products amplified from a plasmid containing
cloned human rDNA sequence using primers 5'‐GGGCTCGAGATTTGGGACGTCAGCTTCTG
and 5'¬GGGTCTAGAGTGCTCCCTTCCTCTGTGAG) at 65° C overnight. Following two rinses
in 2X SSC/1% SDS solution and two rinses in 0.5X SSC/1% SDS, the gels were exposed
using a PhosphorImager casette (Molecular Dynamics) with subsequent imaging in a
PhosphorImager.
Sister chromatid exchange analysis
Sister chromatid exchanges were prepared and visualized essentially as
described [Perry P and Wolff S 1974]. BrdU was added to growing cells at a
concentration of 20 µM, and cells were grown in the dark for two rounds of division.
Colcemid (0.02 µg/mL) was added to medium. Approximately 4 hours later, cells were
harvested with trypsin 0.025% (adherent cells only) and centrifuged for 5 minutes at 200
X g. Medium was aspirated and cells were resuspended in 8 mL hypotonic solution (46.5
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mM KCl/8.5 mM sodium citrate). Cells were incubated at 37° C for 12 minutes, after
which 2 mL of 3:1 methanol:acetic acid fixative was added. Cells were centrifuged at 200
X g for 5 minutes. Hypotonic/fixative solution was aspirated and cells were resuspended
in 3:1 methanol acetic acid fixative and centrifuged at 200 x g. This process was
repeated for a total of three washes in 3:1 methanol:acetic acid fixative. Finally, cells
were dropped onto cold, wet pretreated (0.1N HCL in 95% EtOH) microscope slides and
dried completely on a 45° C heat block. For staining, slides were incubated at room
temperature in 10 µg/mL Hoechst 33258 in water, rinsed in Sorensen’s buffer (0.1M, pH
6.8: equal volumes 0.1 M Na2HPO4 and 0.1 M KH2PO4) and exposed with cover slips to
365 nm UV on a 55° C heat block for 25 minutes. Cover slips were removed and slides
were incubated for 1 hr in 1X SSC at 50° C. Slides were then stained in 10% Giemsa in
Sorensen’s buffer for 30 minutes, rinsed in water, and dried overnight on the benchtop.
Individual metaphase spreads were photographed using bright‐field microscopy and a
60X oil immersion objective.
Drug sensitivity screen
The in vitro growth inhibition screen of NCI‐60 screen with a single 10 µM dose
of 5‐hydroxymethyl‐2'‐deoxyuridine (hmdUrd) was performed by the National Cancer
Institute’s Developmental Therapeutics Program according to the methods described
(http://dtp.nci.nih.gov/branches/btb/ivclsp.html).
5.4: RESULTS AND DISCUSSION
For these experiments, we used our gene cluster instability (GCI) assay to
measure dysregulated recombination by identifying changes in the lengths of ribosomal
RNA gene (rDNA) clusters. High molecular weight genomic DNA was digested with
EcoRV (New England Biolabs), which cuts approximately every 6600 bases in the human
genome [NEB 2010], but does not have a recognition site within the single rDNA repeat.
The sequence of these repeats is highly conserved, and thus, an enzyme which does not
cut within a single repeat generally does not cut anywhere in the cluster of tandemly
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repeated genes, and the entire cluster can be separated from rest of the genomic DNA
by pulse‐field gel electrophoresis, and identified by Southern blot. We have found that a
pulse‐field gel with a resolution limit of 1MB is the most informative for tracking
changes in cluster length associated with GCI.
We used this approach to screen the entire NCI‐60 panel of 59 cancer cell lines
to identify those which showed evidence of rDNA cluster instability (Figure 5.1). We
have previously shown that Bloom syndrome cells, which demonstrate a ladder‐like
banding pattern, are highly unstable on GCI analysis [Killen MW et al 2009]. It was on
this basis that we identified six lines which demonstrated laddering indicative of
instability as candidates for further analysis. Three of these were lung cancer lines
(A549, EKVX, and NCI‐H23), one was leukemia (K562), one was breast cancer (T47D),
and one was renal cancer (TK10). According to our previous findings in tumor versus
non‐tumor tissue from the same patient, the frequency of rDNA cluster instability is
about 50%, as indicated by any variation in banding pattern between the normal and
malignant tissue at 1 MB resolution limit [Stults DM et al 2009]. For these experiments,
we did not have access to normal tissue for comparison, and it is likely that many more
than the six lines we chose are unstable.
Central nervous system (CNS) cell lines SNB19 and U251 were derived from the
same patient. According to our GCI results (Figure 5.1), they demonstrate a similar
pattern, with four common bands, but also deviate from one another with a total of five
bands which are not shared, indicating that the rDNA has continued to undergo
rearrangement in culture. NCI/ADR‐RES and OVCAR‐8 are also derived from the same
patient, but NCI/ADR‐RES has acquired adriamycin resistance. These lines share three
common bands, but NCI/ADR‐RES appears to have acquired an additional band in
culture. The fact that these two lines demonstrated so little divergence in culture
despite the adriamycin‐mediated DNA damage and acquired resistance indicates that
accumulated damage is not sufficient to cause gene cluster instability. A third pair,
MDA‐MB‐435 and M14, are also derived from the same donor. However, these lines
have only a single band below 1MB and it appears stable.
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Nine of the NCI‐60 lines (HCT‐116, HCT‐15, KM12, DU‐145, CCRF‐CEM, MOLT4,
SK¬MEL2, IGR‐OV1, SK‐OV‐3) are known to demonstrate microsatellite instability
indicative of mismatch repair defects [CGP 2008]. It is notable that none of the
mismatch‐repair deficient lines showed evidence of dysregulated recombination on the
initial GCI screen. Although genomic instability is a hallmark of cancer, it is possible that
a tumor cell may only need a single means of acquiring instability to confer a selective
advantage; and thus mismatch repair defects and recombination defects are mutually
exclusive within a given tumor cell.
For the six lines which showed laddering similar to Bloom syndrome, we
undertook a subclone analysis to determine whether dysregulated recombination and
subsequent instability was an ongoing process. We duplicated our approach from the
previous Bloom syndrome experiments. We began by isolating and growing up colonies
derived from a single cell from the populations which demonstrated laddering. In
general, the parental population derived from a single cell usually demonstrates an
initial, well‐defined banding pattern. We called this pattern the “major banding
pattern.” Colonies from single cells from the cloned parental plate were grown up and
GCI analysis was performed. As each clonal population expands, if the rDNA clusters are
completely stable, the initial cluster lengths found in the parental line will be faithfully
transmitted to all subsequent daughter cells (Fig. 5.2, ‘No GCI’). Alternatively,
recombination in the expanding population can generate sub‐populations with altered
gene cluster lengths. Since these sub‐populations only represent a fraction of the total
population, bands will be reduced in intensity accordingly. We called these reduced‐
intensity bands the “minor banding pattern” (Fig. 5.2, ‘Low GCI’). The amount of this
minor‐intensity banding found in any cell population is indicative of the degree of GCI in
that population. Since recombination requires precise alignment of homologous
sequences, cluster lengths can only change by integer multiples of the unit repeat
length. This constraint upon allowable gene cluster lengths (Fig. 5.2, dotted lines) means
that very high levels of instability will generate a ladder‐like pattern of bands (Fig. 5.2,
‘High GCI’), consistent with a recombination‐based mechanism. If cluster length
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alterations were due to random breakage and rejoining, a smear would be observed,
rather than a ladder [Killen MW 2009]. As in the case of Bloom’s syndrome, lines which
demonstrated a laddering pattern in the population sometimes showed non‐
stoichiometric bands within the parental population, indicating a high degree of
instability even within the first parental expansion.
Lung cancer cell line A549 does not appear to demonstrate ongoing rDNA cluster
instability (Figure 5.3A). The major banding pattern from the clonal parental line is
faithfully transmitted to each of the daughter lines with the exception of a single
additional major band in subclone E (open triangle). Lung cancer line NCI‐H23 shows
similar results, with the disappearance of a single band in subclone D (Figure 5.3B). All
nine subclones also appear to have lost two bands that are non‐stoichiometric but
apparent in the parental line. This is not believed to be due to dysregulated
recombination. NCI‐H23 does not form single‐cell‐derived colonies easily. Cells tend to
migrate toward one another, and it may be that the parental population was not purely
derived from a single cell. The third lung cancer cell line, EKVX is classified as having Low
GCI. The parental line shows a single non‐stoichiometric band thought to have arisen
during expansion. Three of the subclonal lines appear to have inherited this band
(subclones C, E, and G), while the other five (A, B, D, F, and H) did not. (Figure 5.3C). In
contrast, the renal cell cancer TK10 was characterized as having high GCI. Among the
nine subclones there were a total of nine new minor bands (black arrows), 24 major
bands either new or inherited from minor bands in the parental population (open
triangles), and 35 deletions of either major or minor bands from the parental population
(brackets) (Figure 5.3D). K562 also showed high GCI, with three new minor bands (black
arrows), six new major bands (open triangles), and nine major band deletions (brackets)
among the 11 subclones (Figure 5.3E). Interestingly, K562 subclones also showed a
stoichiometric laddering pattern of bands that differ by a length of a single unit repeat
(black dots) in the lower range of the gel. We do not believe these arose by
dysregulated homologous recombination, but the mechanism is unclear. Although we
did not observe this phenomenon in any of the other subcloned lines, it does sometimes
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develop in solid tumor and non‐tumor tissue. This phenomenon may be due to a fragile
site within the repeat that causes breakage of the clusters during processing. T47D also
appeared unstable on subclone assay, with the appearance of eight new minor bands
(black arrows), five new major bands (open triangles), and one major band deletion
(bracket) across eight subcloned lines (Figure 5.2F). We also expanded a parental clone
and conducted subclone analysis for MCF7, a breast cancer line that is well
characterized and frequently used for molecular biology experiments. MCF7 did not
demonstrate laddering on the initial screen and showed only two major bands below
the 1MB resolution limit of the gel. MCF7 subclones showed two new minor bands
(black arrows) and no new major bands or deletions among the eight subclones (Figure
5.3G). In summary, of the six lines we identified as definitively demonstrating rDNA GCI
instability on initial screen, only three (T47D, TK10, and K562) continue to show
evidence of ongoing instability at the present time.
We performed sister chromatid exchange analysis on five of our six lines which
showed initial and/or ongoing instability (EKVX, NCI‐H23, T47D, TK10, and K562), in
order to explore whether there was any correlation between gene cluster instability and
sister chromatid exchange (Figure 5.4A). There appears to be some inherent variability
in the range. In general, the SCE distributions are different across cell lines (Kruskal‐
Wallis test p‐value = 0.0001). However, none is notably unstable by SCE, as the
distributions all overlap. In pair‐wise comparisons of the mean values for each of the 5
cell lines, the mean value for TK10 was significantly lower than the other four cell lines
tested (p<0.05) (raw, unbinned data not shown), meaning that TK10 exhibits
significantly fewer exhanges per chromosome than the other cell lines. In no case was
there a correlation between elevated instability on GCI and notable instability on SCE.
Previous experiments with wild type fibroblasts (GM00637), which are stable on GCI,
show similar values by SCE analysis (unpublished data). Single isolated metaphases
from K562 (1/39) and NCI‐H23 (1/20) did show between three‐and four‐fold elevation in
the number of sister chromatid exchanges, but the significance of these findings is
unclear.
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In addition to its ongoing instability on GCI, K562 also appeared to demonstrate
evidence of increased instability by sister chromatid exchange in two subcloned lines
(Figure 5.4B). Although the original population of K562 cells did not show gross
elevation above other cell lines or wild type, K562p1 and K562p3, both of which were
lines expanded from a single cell of the population, did show a 1.5‐fold elevation in
sister chromatid exchanges in 37% and 38% of the metaphases scored, respectively. In
addition, 13% of K562p1 metaphases and 25% of K562p3 showed exchanges of greater
than 0.3125 per chromosome. Comprehensive analysis of metaphases from individual
subclones for all of the lines tested for GCI was beyond the scope of these experiments;
and it is possible that upon examination, all of five of the cell lines would have
demonstrated instances of increased instability by SCE. However, it is interesting to
note that K562 did show ongoing instability by GCI, as well as a trend toward increased
instability on SCE, which points to a shared mechanism or partial mechanism for both
phenomena. On the other hand, TK10, which is highly unstable by GCI, is remarkably
stable by SCE in our hands.
XRCC1 knockdown in CHO and HeLa cells has been shown to lead to an increase
in sister chromatid exchange [Fan J et al 2007;Thompson LH 1982]. Downregulation of
XRCC1 also confers sensitivity to 5‐hydroxymethyl‐2’‐deoxyuridine in HeLa cells [Fan J et
al 2007]. We wished to determine whether there was any correlation between hmdUrd
sensitivity and genomic instability by SCE assay, GCI assay, or both. In collaboration with
the Developmental Therapeutics Program Screening Service at NCI, we screened the
entire NCI‐60 panel for sensitivity a 10 µM dose of hmdUrd (Figure 5.5A). Six lines were
notable for sensitivity to hmdUrd at this dose. Hop62, SNB19, and Ovcar‐5 were
moderately sensitive (mean growth approximately ‐50%), U251 and NCI‐Adr/Res were
highly sensitive (mean growth approximately ‐75%), and 786‐0 was extremely sensitive
to hmdUrd (‐100% mean growth). None of these lines were notable for pronounced
genomic instability by GCI or SCE analysis (Figure 5.5B).
Interestingly, however, U251 showed higher hmdUrd sensitivity than did SNB19,
which is from the same donor. They show similar ranges and mean values on SCE
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analysis, but U251, the more sensitive line, showed a higher proportion of metaphases
with greater than 0.1875 exchanges per chromosome. Ovcar‐8 displayed no sensitivity
to hmdUrd at the 10 µM dose, but NCI‐Adr/Res, the adriamycin‐resistant line from the
same donor, was highly sensitive to the drug. We did not detect any differences
between these two lines on SCE. Renal cell line 786‐0, the most sensitive line for
hmdUrd, showed a normal range of stability for SCE. However, on GCI, 786‐0 showed no
rDNA bands below 1 Mb (Figure 5.1). We did not find this remarkable since Southern
blot showed there was indeed ribosomal DNA beyond the resolution limit of the gel;
and we did no further analysis. However, in light of the marked hmdUrd findings, we
speculate that there may be a connection between loss of smaller rDNA gene clusters
and hmdUrd sensitivity.
We were surpised to find laddering on rDNA GCI did not correspond with
markedly elevated sister chromatid exchange in the NCI‐60 panel. In normal cells,
homologous recombination which results in crossovers and physical restructuring of
DNA is suppressed due to its potential to cause damage. In searching the NCI‐60
database, we did not find any consistent mutations or remarkable changes in repair‐
associated mRNA levels across the lines which demonstrate laddering. However, HR is
an extremely complex and not fully understood process involving over 200 DNA repair
and checkpoint proteins [Helleday T, 2010]. Checkpoint defects or mutations in lesser
known components of HR may allow cells to proceed through the cell cycle with
partially duplicated and broken rDNA. The ribosomal RNA gene contains its own origin
of replication and also possesses sequences which make formation of G‐quartets and
fragile sites very likely, and it is possible that BLM suppresses rDNA cluster instability via
a different mechanism than the one for suppressing SCEs. We were also surprised to
find that the hmdUrd results for the NCI‐60 panel of human cell lines did not correspond
well to what has been shown in CHO cells, but perhaps this finding is not so remarkable
and points to the vast differences in physiology and metabolism between humans and
rodents, emphasizing the need to abstain from making direct inferences with regard to
issues of human health based on findings in model organisms.

64

FIGURE 5.1: GCI SCREEN OF THE NCI‐60 PANEL OF HUMAN CANCER CELL LINES

NCI‐60 panel of cell lines grouped according to primary histology. Open star (
) indicates resolution limit 1 Mb. Red boxes indicate lines with laddering indicative of
GCI. Red text: NCI/ADR‐RES and OVCAR‐8 from same donor. Blue text: MDA‐MB‐435
and M14 from same donor. Fuscia text SNB‐19 and U251 from same donor. Green
text: Lines with known microsatellite instability according to the Cancer Genome
Project.
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FIGURE 5.2: SUBCLONE ASSAY TO MEASURE RATE OF GCI

Schematic of GCI patterns in clonal cell lines. A single cell shows a well‐defined pattern
of gene cluster lengths (‘Initial Pattern’—thick bands). Allowable, but currently
unrepresented gene cluster lengths are shown as dotted lines. As mitotic division
expands the clonal cell population in the absence of instability, gene cluster lengths
are faithfully preserved (‘No GCI’). Alternatively, instability generates sub‐populations
within the expanding population with altered cluster lengths giving rise to lower
intensity ‘minor bands’ (‘Low GCI’—thin bands indicated by arrows). High levels of
instability generate a ladder‐like pattern of minor banding with individual bands on
the ladder differing by integer multiples of the unit repeat length (‘High GCI’).
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FIGURE 5.3A: A549 SUBCLONE EXPANSION

A clonal population of lung cancer cells derived from a single cell is shown in the
leftmost lane. Sub‐clones were derived by dilution plating to single cells with
subsequent expansion. Changes to the major banding pattern are shown by triangles
(new bands).
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FIGURE 5.3B: H23 SUBCLONE EXPANSION

A clonal population of lung cancer cells derived from a single cell is shown in the
leftmost lane. Sub‐clones were derived by dilution plating to single cells with
subsequent expansion. Changes to the major banding pattern shown by brackets
(missing bands).
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FIGURE 5.3C: EKVX SUBCLONE EXPANSION

A clonal population of lung cancer cells derived from a single cell is shown in the
leftmost lane. Sub‐clones were derived by dilution plating to single cells with
subsequent expansion. Minor bands indicated by arrows. Changes to the major
banding pattern shown by triangles (new bands) and brackets (missing bands).
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FIGURE 5.3D: TK10 SUBCLONE EXPANSION

A clonal population of renal cancer cells derived from a single cell is shown in the
leftmost lane. Sub‐clones were derived by dilution plating to single cells with
subsequent expansion. Minor bands indicated by arrows. Changes to the major
banding pattern shown by triangles (new bands) and brackets (missing bands).
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FIGURE 5.3E: K562 SUBCLONE EXPANSION

A clonal population derived from a single cell is shown in the leftmost lane. Sub‐clones
were derived by dilution plating to single cells with subsequent expansion. Minor
bands indicated by arrows. Changes to the major banding pattern shown by triangles
(new bands) and brackets (missing bands).
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FIGURE 5.3F: T47D SUBCLONE EXPANSION

A clonal population of breast cancer cells derived from a single cell is shown in the
leftmost lane. Sub‐clones were derived by dilution plating to single cells with
subsequent expansion. Minor bands indicated by arrows. Changes to the major
banding pattern shown by triangles (new bands) and brackets (missing bands).
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FIGURE 5.3G: MCF7 SUBCLONE EXPANSION

A clonal population of breast cancer cells derived from a single cell is shown in the
leftmost lane. Sub‐clones were derived by dilution plating to single cells with
subsequent expansion. Minor bands indicated by arrows.
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FRACTION OF METAPHASES SCORED

FIGURE 5.4A: SISTER CHROMATID EXCHANGE ASSAY OF GCI UNSTABLE LINES

AVERAGE SCEs PER CHROMOSOME
Sister chromatid exchange analysis of populations from cell lines that are unstable by
GCI assay. X‐axis: Average number of sister chromatid exchanges per chromosome. Y‐
axis: Proportion of metaphases scored. All five lines appear relatively stable by sister
chromatid exchange assay. However, K562 and H23 do show occasional metaphase
spreads which contain a markedly elevated number of exchanges.
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FRACTION OF METAPHASES SCORED

FIGURE 5.4B: SISTER CHROMATID EXCHANGE ASSAY OF K62 SUBCLONES

AVERAGE SCEs PER CHROMOSOME
Sister chromatid exchange analysis of metaphase spreads from two subclones
expanded from K562 population. X‐axis: Average number of sister chromatid
exchanges per chromosome. Y‐axis: Proportion of metaphases scored. In general,
most of the metaphase spreads from both subclones are stable range. However,
22.5% of the K562p3 metaphases showed > 3.6 fold elevation. K562p1 subclones
showed 5% of metaphases with >2 fold elevations.
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FIGURE 5.5A: 5‐HYDROXYMETHYL‐2'‐DEOXYURIDINE SENSITIVITY

NCI‐60 panel was tested for sensitivity to a single 10 μM dose of 5‐hydroxymethyl‐2'‐
deoxyuridine, a thymidine analog. The lines shown in red had reduced growth in the
presence of the drug.
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FRACTION OF METAPHASES SCORED

FIGURE 5.5B: SISTER CHROMATID EXCHANGE ASSAY HMDURD SENSITIVE LINES

AVERAGE SCEs PER CHROMOSOME
Sister chromatid exchange analysis of metphases from populations of cell lines that
are sensitive to 5‐hydroxymethyl‐2'‐deoxyuridine. X‐axis: Average number of sister
chromatid exchanges per chromosome. Y‐axis: Proportion of metaphases scored.
There is no correlation between hmdUrd sensitivity and increased number of sister
chromatid exchanges.
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CHAPTER 6: CONCLUSIONS AND FUTURE DIRECTIONS
This dissertation represents my efforts to characterize the genomic architecture
of the human ribosomal RNA gene clusters and evaluate their heritability and stability in
normal healthy individuals. Using the NCI‐60 panel of cell lines in culture, I have also
attempted to determine whether cancer‐associated architectural destabilization in
these clusters correlates with two other known recombination‐mediated functional
phenotypes: increased levels of sister chromatid exchange, and sensitivity to
5¬hydroxymethyl‐2’‐deoxyuridine. Key findings are summarized below.
Chapter 4 describes my initial use of a new assay, the gene cluster instability
(GCI) assay, to determine the actual number of repeats in ribosomal RNA gene clusters
(rDNA), since they cannot be adequately assembled by the Human Genome Project. The
assay, developed by Dr. Andrew Pierce, Michael W. Killen, and me, utilizes restriction
enzyme digestion of very high molecular weight DNA fragments followed by pulsed‐field
gel electrophoresis and in‐blot Southern hybridization to monitor changes in the lengths
of the clusters. Much attention has been paid recently to gene copy number variation in
the human population. It is believed that copy number differences and subsequent
dosage variation accounts for a great deal of the phenotypic differences between
individuals [Smith S et al 2006; Redon R et al 2006; Sebat J et al 2004]. Comparative
genomic hybridization (CGH) is often used as a means for tracking these changes; but
sensitivity is limited to those genes that demonstrate at least a 3‐fold difference in copy
number. CGH is not effective for tracking changes in gene cluster lengths which vary by
single integer repeats. Using our GCI approach, I found that normal, healthy humans are
completely heterozygous for their repeat cluster lengths within each individual and
throughout the population. In general, cluster lengths are inherited from both parents.
However, meiotic rearrangement of the clusters does occur frequently, and I also saw
evidence of mitotic non‐allelic homologous recombination. I determined that there are
about 600 copies of the 45S ribosomal genes in each human diploid cell. There are
about 200 copies of the 5S ribosomal RNA genes. This work established the baseline
level of stability and rate of change for ribosome RNA gene clusters in humans,
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definitively demonstrating that these genes do undergo NAHR as predicted based on
their structure. The results were published in 2008, in Genome Research [Stults DM et
al, 2008].
Based on the results from my initial studies, I sought to determine whether
cancer cells may be subject to increased levels of NAHR compared to normal tissue. I
hypothesized that the characteristic genomic destabilization in cancer may in some
cases be due to dysregulated homologous recombination. I used our GCI assay to
compare 45S rDNA gene cluster instability in normal tissue and tumors from clinical
cancer patients at the University of Kentucky Markey Cancer Center. The results, shown
here in Appendix A, were part of an MS thesis project and were published in the journal,
Cancer Research. From analysis of samples from 39 patients, I found that over half of
the adult solid tumors show detectable rDNA rearrangements relative to either
surrounding non‐tumor tissue or normal peripheral blood. This instability may cease
before expansion, or it may continue. About 25% of the tumors demonstrate a laddering
pattern of heterogeneous cluster lengths within the tumor cell population, similar to
that of BLM fibroblasts [Killen MW et al 2009]indicating ongoing instability. Pediatric
leukemias did not demonstrate laddering. These findings indicate that rDNA
restructuring is among the most common chromosomal alterations in adult solid
tumors, and may prove to have either prognostic or predictive value [Stults DM et al
2009].
Chapter 5 of this dissertation represents my use of the NCI‐60 panel of human
cancer cell lines to correlate dysregulated and non‐allelic homologous recombination as
evidenced by the GCI assay with two other phenotypic measures of recombination: the
sister chromatid exchange assay, and hmdUrd sensitivity. Based on evidence from
Bloom syndrome cells which show both laddering on GCI and 10‐fold elevation in sister
chromatid exchange, I hypothesized that those cell lines from the NCI‐60 panel which
demonstrate laddering would also demonstrate evidence of recombination‐mediated
instability on sister chromatid analysis. I further hypothesized that hyper‐recombinative
cell lines may also show increased sensitivity to hmdUrd. I speculated that in those cell
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lines where recombination is already up‐regulated, as evidenced by GCI or SCE assay,
interfering with base‐excision repair by using hmdUrd may cause synthetic lethality, as
hyper‐recombinative cells may not be able to compensate by further up‐regulating HR. I
had hoped that by using the extensively characterized NCI‐60 panel and the Cancer
Genome Project database, I might be able to uncover a common genetic mechanism for
dysregulated recombination as a means for conferring genomic instability in cancer.
Surprisingly, I did not find any correlation between rDNA cluster instability on
GCI compared to SCE or hmdUrd sensitivity, although these experiments did yield
interesting findings. I was able to determine rDNA cluster instability on GCI is anti‐
correlated with microsatellite instability, the result of a mismatch repair defect, which
led me to speculate that in general, genomic destabilization arises by a single
mechanism.
Sister chromatid exchange analysis of populations from twelve cell lines indicates
that the level of baseline sister chromatid exchange in the presence of BrdU varies
between cell lines, though none of the lines demonstrated the harlequin pattern of
gross destabilization characteristic of Bloom syndrome chromosomes, and thus are all
considered “stable” by SCE analysis. Sister chromatid exchange is therefore thought to
be cell‐line dependent and able to change in culture; as even cell lines originally derived
from the same patient show varying levels of instability.
Unlike the XRCC‐1 deficient CHO cells, none of the human cell lines which
demonstrated sensitivity to a single 10µM dose of hmdUrd were notable for base
excision repair defects, according to the Cancer Genome Project database, which
indicates that HmdUrd sensitivity may be conferred via some mechanism other than
inability to overcome damage by base excision repair.
At the present time, other members of the lab are pursuing some of the genetics
underlying rDNA gene cluster instability, particularly with regard to Bloom syndrome
and other RecQ helicases. Tandemly repeated gene clusters located elsewhere in the
genome are also being evaluated to determine whether gene cluster instability is an
rDNA‐specific phenomenon.
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In the future, I will expand on the findings from Appendix A. I will undertake a
comprehensive analysis of rDNA GCI in clinical lung cancer patients to determine
whether their tumor GCI status has prognostic value or can be correlated with response
to chemotherapy. Current clinical staging is based on a number of factors including the
size and appearance of the tumor, whether or not there are multiple loci , lymph node
involvement, and metastasis to other organs. Our preliminary data indicate that
patients who demonstrate molecular GCI instability are otherwise clinically identical
their stable counterparts on presentation. It is reasonable to predict that although from
the clinical perspective patients may be similar, whether or not they are undergoing
remarkable genomic rearrangement at the molecular level may influence their
prognosis and/or clinical response to treatment.
Regardless of the outcome of my studies, the profoundly different GCI results
between patients of identical clinical status merits further investigation. I speculate that
the patients who demonstrate the laddering pattern on GCI indicative of ongoing rDNA
repeat destabilization may have a better long‐term prognosis and/or response to
treatment. I have proposed using late‐stage patients because lung cancer survival is
abysmal, less than five years; and a study of two years' duration will be sufficient to
determine whether there are any differences in survival between those with and
without ongoing instability. However, if I am able to extract reasonably intact DNA from
frozen tissue, it may be possible to use banked samples from patients with earlier stage
disease. I could use earlier stage samples, and thus interpret response to treatment in
patients whose intervention has been early enough to have some effect.
The marked ongoing instability in some but not all of the solid tumors I tested is
also intriguing. It has become apparent that the tumors of some non‐small cell lung
cancer patients demonstrate genomic alterations such as fusions and translocations,
representing new targets for custom‐designed therapeutics (Horn and Pao, 2009).
Because of their tendency for rearrangement, the rRNA genes, in addition to playing a
direct role in cell metabolism, may also drive oncogenesis via this mechanism. By
determining whether there is altered sequence context for the rRNA genes, I may
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uncover an exciting new therapeutic target for a clinical subset of NSCLC patients. I
hypothesize that for those patients who demonstrate temporal rDNA cluster instability,
translocation of the rRNA gene, promoter, and/or immediate upstream regulatory
region may be influencing expression of oncogenes to promote increased metabolism,
unrestrained proliferation, and/or avoidance of apoptosis. I have proposed experiments
using restriction digest, cloning, PCR, and sequencing to determine whether there are
alternative sequence contexts for the rRNA genes or regulatory elements that serve to
drive tumorigenesis in clinical cancer patients.
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Appendix A
Molecular Biology, Pathobiology, and Genetics

Human rRNA Gene Clusters Are Recombinational Hotspots in Cancer
Dawn M. Stults,1,8 Michael W. Killen,2,8 Erica P. Williamson,3 Jon S. Hourigan,4,7,8
H. David Vargas,4,7,8 Susanne M. Arnold,5,7,8 Jeffrey A. Moscow,6,7,8 and Andrew J. Pierce1,2,7,8
1
Graduate Center for Toxicology, Departments of 2Microbiology, Immunology and Molecular Genetics and 3Biology, 4Section of Colon and
Rectal Surgery, Division of General Surgery; Departments of 5Internal Medicine and 6Pediatrics, Division of Hematology-Oncology;
7
Markey Cancer Center; and 8College of Medicine, University of Kentucky, Lexington, Kentucky

Abstract

remaining components of the human genome with no representation in the Human Genome Project.
The highly repetitive nature of these clustered genomic repeats
also prevents the application of commonly used techniques to investigate genomic instability such as array-based comparative genome hybridization, single nucleotide polymorphism (SNP)
analysis, and high-throughput paired end sequencing approaches.
Nevertheless, the very considerations that make the rDNA clusters
difficult to study by conventional means also make the rDNA biologically interesting from a genomic stability perspective. The
sequence conservation, repeat length, and high relative local concentration of the repeats involving multiple chromosomal loci are,
in principle, conducive to cluster restructuring by homologous recombination. We previously physically characterized human rDNA
cluster lengths, finding an average of 600 repeats per diploid genome spread over the 10 rDNA clusters, subject to wide personto-person variability driven by strong meiotic recombination; the
number of gene repeats per cluster changes with a frequency of
∼10% per cluster per meiosis (3). The high meiotic recombination
frequency phenotype of the rDNA leads us to consider whether the
rDNA clusters could serve as sentinel biomarkers for dysregulated
mitotic recombination in cancer.
Dysregulated recombination has the potential to mediate genomic restructuring in cancer (reviewed in ref. 4). We recently
showed that changes in rDNA cluster lengths in cultured mitotic
human cells are potential indicators of recombination-mediated
genomic destabilization by showing a 10- or 100-fold increase in
the frequency of spontaneous rDNA cluster restructuring in cells
deficient for the ataxia-telangiectasia mutated (ATM) protein or
the Bloom syndrome protein, respectively (5), in line with the increased prevalence of malignancy in ATM (6) and Bloom syndrome
(7) patients. To determine whether the rDNA clusters are restructured in sporadic cancers generally as well as in cancer predisposition syndromes such as ATM and Bloom syndrome, we
prospectively recruited lung cancer, colorectal cancer, and pediatric leukemia patients for molecular analysis of their disease.
Lung and colorectal cancers are the leading and second leading
cause of American deaths from cancer, accounting for 28% and 9%
of all cancer deaths, respectively (8). Notably, both lung and colorectal cancers derive from tissues with potentially substantial exposure
to environmental genotoxic agents. Many potential environmental
carcinogens, including specifically those in tobacco smoke, are potent inducers of sister chromatid exchange (9–11), which is thought
to occur by a recombination-based mechanism (12). Ordinarily,
mammalian cells efficiently suppress recombination-mediated genomic rearrangements (13, 14), but damage or loss of this control
of recombination, combined with protracted recombination induction by environmental agents, may significantly impact the etiology
of tumors in these organs. Evidence suggesting potential cancer etiology relevance for dysregulated recombination, particularly in the

The gene that produces the precursor RNA transcript to the
three largest structural rRNA molecules (rDNA) is present in
multiple copies and organized into gene clusters. The 10 human rDNA clusters represent <0.5% of the diploid human genome but are critically important for cellular viability.
Individual genes within rDNA clusters possess very high levels
of sequence identity with respect to each other and are present in high local concentration, making them ideal substrates
for genomic rearrangement driven by dysregulated homologous recombination. We recently developed a sensitive physical assay capable of detecting recombination-mediated
genomic restructuring in the rDNA by monitoring changes
in lengths of the individual clusters. To prove that this dysregulated recombination is a potential driving force of genomic
instability in human cancer, we assayed the rDNA for structural rearrangements in prospectively recruited adult patients
with either lung or colorectal cancer, and pediatric patients
with leukemia. We find that over half of the adult solid tumors
show detectable rDNA rearrangements relative to either surrounding nontumor tissue or normal peripheral blood. In contrast, we find a greatly reduced frequency of rDNA alterations
in pediatric leukemia. This finding makes rDNA restructuring
one of the most common chromosomal alterations in adult
solid tumors, illustrates the dynamic plasticity of the human
genome, and may prove to have either prognostic or predictive
value in disease progression. [Cancer Res 2009;69(23):9096–104]

Introduction
The human rRNA gene clusters (rDNA clusters) produce 45S
precursor transcripts, subsequently processed to make three of
the four structural RNA components of the ribosome, and are critically required for protein synthesis and cellular viability. The
rDNA clusters comprising collectively hundreds of gene copies
are located on the short arms of the five human acrocentric
chromosome pairs (13p12, 14p12, 15p12, 21p12, 22p12: OMIM
180450-180454) and are generally organized with individual genes
in head-to-tail tandemly repeated arrays (1). Each individual gene
is each 43-kb in length (2), with near perfect sequence conservation. Extremely high sequence similarity combined with the length
of the individual repeats makes both shotgun-based and directed
sequencing approaches to genome sequence assembly of the rDNA
impossible. As a result, the rDNA clusters are one of the largest
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GATTTGGGACGTCAGCTTCTG and 5′-GGGTCTAGAGTGCTCCCTTCCTCTGTGAG on pBSrDNA11, a pBluescript-based (Stratagene)
plasmid containing a subcloned and sequenced segment of the human
rDNA intergenic spacer, generated by using the aforementioned primers
to amplify human genomic DNA (3). Gels were rinsed at 65°C with 2×
SSC/0.1% SDS followed by 0.5 × SSC/0.1% SDS, briefly equilibrated with
2× SSC, and developed by exposing a PhosphorImager cassette with subsequent imaging in a PhosphorImager (Molecular Dynamics). Raw data were
obtained in TIFF format and processed using Adobe Photoshop. All images
were processed en bloc. In no case did image processing either obscure
bands from the raw data, or cause bands not apparent in the raw data
to appear.

case of lung cancer, includes both the overexpression of recombination genes (15) and ATM defects commonly found in this tissue (16).
Conversely, pediatric leukemia is thought to be driven by specific
chromosomal events, rather than the gradual accumulation of malignant features caused by many years accumulating molecular genomic insults (17). This work reports the result of testing the
hypothesis that dysregulated recombination is a significant feature
of primarily sporadic adult lung and colorectal cancers rather than
pediatric leukemias.

Materials and Methods
Human investigations were performed after approval by the University
of Kentucky Institutional Review Board and Markey Cancer Center Protocol Review Committee, and in accordance with an assurance filed with and
approved by the Department of Health and Human Services. Informed consent was obtained from University of Kentucky Medical Center patients
undergoing surgical resection for either lung or colorectal cancer, or from
the parents of pediatric patients being treated for leukemia. For patients
with solid tumors, peripheral blood was drawn before surgery. After surgery, resected specimens were examined by the Division of Surgical Pathology, and pieces of both tumor and surrounding nontumor tissue were
removed for analysis. Leukemia patients had either peripheral blood or
bone marrow aspirates removed for analysis periodically throughout the
course of their treatment. All patient samples are referred to in this work
by study code names.
Sample processing. Solid tissues were rinsed on ice in RPMI1640 containing antibiotics and 10% fetal bovine serum (RPMI/FBS). Tissues were
then disaggregated to single cells mechanically either by gentle scraping
and mincing, or by mincing in RPMI/FBS and processing in a 50-μm pore
size Medicon unit in a MediMachine followed by debris removal by filtration with a 70-μm pore size Filcon (all from Becton Dickinson). For whole
blood and bone marrow aspirates, leukocytes were isolated by ammonium
chloride lysis. No digestive enzymes were used in the preparation of any of
the single-cell suspensions. Single-cell suspensions of either leukocytes or
solid tissues had DNA-containing cells quantified by vital staining with 2
μg/mL acridine orange followed by flow cytometric analysis with a 488-nm
argon-ion laser triggering acquisition on green fluorescence (DNA content)
essentially as described (18). Single-cell suspensions were adjusted to 1 ×
107 cells/mL final concentration in 0.8% low-melting-temperature agarose
and allowed to solidify. High-molecular-weight genomic DNA was prepared
from this solid phase cell suspension by treatment with 1% sarkosyl/
500 mmol/L EDTA/0.5 mg/mL proteinase K at 50°C for at least 16 h, followed by treatment with phenylmethylsulfonyl fluoride, extensive rinsing,
and final equilibration in 50% glycerol/10 mmol/L Tris/1 mmol/L EDTA
(pH 8.0) and long-term storage at −20 C.
Southern blot analysis. The rDNA clusters were analyzed by pulsedfield gel electrophoresis and Southern blotting as described (3). Approximately 1 μg genomic DNA in a 10-μL solid-phase agarose slice was
equilibrated with appropriate restriction digestion buffer and was digested
by EcoRV (New England Biolabs) to liberate intact rDNA clusters from bulk
genomic DNA. Agarose slices containing digested genomic DNA were sealed
into the wells of a 1% Pulse Field Certified agarose (Bio-Rad) gel in
44.5 mmol/L Tris/44.5 mmol/L boric acid/1.0 mmol/L EDTA [pH 8.0; 0.5×
Tris-borate EDTA (TBE)]. The gels were run using a CHEF-MAPPER (BioRad) in 0.5× TBE for 24 h at 6 V/cm field strength, switching between 120°
separated field vectors (frequency, 3–90 s) using a “ramp factor” of 0.357
(Bio-Rad) at a constant temperature of 14°C to achieve approximately linear
size resolution of between 30 kb and 1 Mb.
Following electrophoresis, gels were equilibrated to 0.5% final concentration glycerol and dried at 65°C. Dried gels were rehydrated with water, denatured with 0.4 N NaOH/0.8 mol/L NaCl, neutralized with 0.5 mol/L Tris
(pH 8.0)/0.8 mol/L NaCl, and prehybridized at 65 C in 2× SSC (300 mmol/L
NaCl/30 mmol/L Na-citrate) with 7% SDS and 0.5% casein. Gels were
probed overnight at 65°C in fresh prehybridization solution using the
rDNA-specific radiolabeled PCR products of primers 5′-GGGCTCGA-
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Results
We assay for dyregulated recombination in the rDNA by examining changes in the physical length of individual rDNA clusters
(Fig. 1). Every person has a unique configuration of these rDNA
clusters (3), so the cluster lengths vary from person to person.
Where possible, we compare the rDNA cluster lengths found in
surgically excised nearby nontumor tissue to the gene cluster
lengths found in the tumor itself, and to gene cluster lengths from
the patients' peripheral blood as an additional control (lanes N, T,
and B, respectively). Our prior experiences with both human blood
and cell lines indicated that analysis of gene cluster lengths from
50 kb to ∼1 Mb is the most informative range for detecting recombination–mediated alterations (3, 5), so this is the methodology we
followed in this present work. Gene clusters larger than 1 Mb all run

Figure 1. Patterns of genomic instability in the rDNA. In each case lanes are
nontumor tissue (N), tumor tissue (T), and peripheral blood (B). The grouped
bands at the star represent unresolved gene clusters larger than 1 Mb. The lower
limit of resolution of the gel is 50 kb. , breakage from fragile DNA not involving
actual chromosomal restructuring.
, new bands found in tumors and not in
nontumor tissue. , new bands found in a fraction of tumor tissue but not
nontumor tissue. Arrows, bands found in nontumor tissue but underrepresented
in tumor tissue.
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Figure 2. Lung squamous cell carcinoma rDNA
stability analysis. rDNA clusters resolved up to 1 Mb
in length (★). N, nontumor tissue; T, tumor tissue;
B, peripheral blood. , sample fragility; , new major
bands found in tumors; , new minor bands found in
tumors. Coded patient names are indicated below
each gel. Differentiation status of tumors: mod,
moderately differentiated; mod/poor, moderately to
poorly differentiated; poor, poorly differentiated.
Any clinical pretreatment is indicated as chemotherapy
and radiation therapy (chemo/XRT). Pathologic staging
of tumors is indicated. Smoking history is given in
person-pack-years (ppy) or when the patient is a
smoker but smoking history has not been obtained
(yes); unk, unknown.

•

together unresolved at the top of the gel in the region (indicated by
the ★) under these electrophoretic conditions, otherwise all unique
gene clusters shorter than 1 Mb are resolved as individual bands.
If the rDNA clusters are stable under mitotic cellular expansion,
the banding pattern found in tumor cells will match that found
in nontumor cells (Fig. 1, Stable). Occasionally, we observe a relatively low-molecular-weight ladder of bands at the bottom of the gel
in tumor and normal tissues (Fig. 1, Sample fragility), consistent

Cancer Res 2009; 69: (23). December 1, 2009
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with the 43 kb rDNA individual gene repeat length. These bands
appear to arise from stochastic, low-frequency fragile-site breakage
in individual rDNA repeats during the genomic DNA isolation procedure itself rather than from bona fide chromosomal alterations in
cells, since the intensities of these bands follows a smooth Gaussian
distribution and is not dependent on liberation of the gene clusters
from bulk genomic DNA by restriction enzyme digestion. Although
this fragility may contribute to initiating chromosomal alterations
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in gene cluster lengths, we do not consider a low-molecular-weight
banding pattern on its own to be indicative of genomic instability.
On the other hand, if a tumor has lost control over recombination, the configuration of gene cluster lengths in the tumor will be
different, relative to nontumor cells (5). If the rDNA cluster length
restructuring occurred before clonal expansion of the prototumor
cell, for example in the lungs of a heavy smoker, the altered length
gene clusters will be present in the entirety of the subsequent tumor. In this case, some bands found in nontumor tissue may be

lost in the tumor, and new bands become evident (Fig. 1, Instability
before expansion). These new bands (Fig. 1, ▸) show intensities
proportional to their length. Tumor samples are commonly contaminated with nontumor tissue, so fainter bands in the tumor
sample occurring at the same position as bands found in normal
tissue likely represent contaminating normal tissue rather than
heterogeneity of cluster lengths within the tumor itself. Finally,
gene cluster lengths may have changed both before clonal expansion of the prototumor cell and also during the clonal expansion

Figure 3. Lung adenocarcinoma rDNA
stability analysis. rDNA clusters resolved
up to 1 Mb in length (★). N, nontumor
tissue; T, tumor tissue; B, peripheral blood.
, sample fragility; , new major bands
found in tumors; , new minor bands
found in tumors. Coded patient names are
indicated below each gel. Differentiation
status of tumors: mod, moderately
differentiated; mod/poor, moderately
to poorly differentiated; poor, poorly
differentiated. Pathologic staging of tumors
is indicated. Smoking history is given in
person-pack-years (ppy), or when the
patient is a smoker but smoking history has
not been obtained (yes); unk, unknown.

•

▸
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Figure 4. Colon adenocarcinoma rDNA stability analysis.
rDNA clusters resolved up to 1 Mb in length (★). N,
nontumor tissue; T, tumor tissue; B, peripheral blood. ,
sample fragility; , new major bands found in tumors; ,
new minor bands found in tumors. Coded patient names
are indicated below each gel. Differentiation status of
tumors: mod, moderately differentiated; mod/poor,
moderately to poorly differentiated; alternatively, tumors
are classified as either mucinous or metastatic. Pathologic
staging of nonmetastatic tumors is indicated. From
lung, likely metastatic colon adenocarcinoma surgically
excised from lung tissue. Smoking history is given in
person-pack-years (ppy), or when the patient is a smoker
but smoking history has not been obtained (yes); no, for
a nonsmoker, unk, unknown.

▸

ties of the “major new bands” in the tumor is determined by
the fraction of the tumor made up of cells with these alterations;
the later in the clonal expansion the gene cluster alteration
occurred, the fainter the minor intensity bands will be. In contrast

of the new tumor. Alterations that occurred after the tumor began
clonal expansion will manifest as new bands, but with reduced
intensity (Fig. 1, Ongoing instability, ▹). The degree to which the
intensity of these “minor bands” is reduced relative to the intensi-
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to the “Sample fragility” bands, new minor bands in the tumor occur at high molecular weights, do not vary smoothly in intensity,
and are dependent on liberation from bulk genomic DNA by restriction digestion before visualization on the gels.
We first analyzed lung squamous cell carcinoma (Fig. 2). Four of
11 patients, TIBBO-JU, PANIU-HA, AFILA-PA, and JIMIL-GE show
no differences between observed gene cluster lengths in tumor relative to nontumor tissues indicating rDNA cluster stability. Two
more patients, RESCA-BO and OFIAT-MA, show the same gene
cluster profiles between tumor and nontumor cells, with the exception of an even laddering of bands in the lower part of the gel (•)
consistent with fragility in the isolated genomic DNA. We therefore
also consider these tumors to be gene cluster stable. The stability
of TIBBO-JU is particularly remarkable because this tumor was a
recurrence following both chemotherapy and radiation treatment.
Clearly, the intense genomic damage from treatment does not necessarily cause loss of gene cluster stability, nor is loss of gene cluster stability necessarily required for poor response to therapy.
The remaining five lung squamous cell carcinomas all show evidence of structural alteration in the rDNA. XEPRY-DA, QIPPI-SH,
and VEKOR-CH show bands found in tumor cells not present in
either blood or surrounding nontumor cells (Fig. 2, ▸). In XEPRYDA and VEKOR-CH, each novel band is ∼30% the intensity of the
bands found in nontumor tissue. This is consistent with either the
rearrangements occurring early in the clonal expansion of the initial prototumor cell, or in the pretumor lung tissue before the initiation of clonal expansion, in which case the tumor would make
up 30% of the cells in the tumor sample, with the remaining 70%
being normal tissue. The novel bands in QIPPI-SH are on the order
of intensity of bands in nontumor tissue, suggesting that these genomic alterations preceded clonal tumor cell expansion.
Finally, two of the poorly differentiated lung squamous cell carcinomas, BONTA-DA and WOFUT-BR, show evidence of extensive
and ongoing recombinational instability. In both cases, there are
new major bands in the tumors not found in nontumor tissue
(Fig. 2, ▸). Significantly, there are additionally several high-molecular-weight minor intensity bands (Fig. 2, ▹). The presence of both
new major and minor intensity bands indicates that not only were
the rDNA clusters altered in the pretumor tissue as might be expected for cells under genotoxic pressure from tobacco exposure,
but that these gene clusters continued to structurally rearrange in
the early history of the tumor after the prototumor cells had already become committed to clonal expansion.
We see a similar level of gene cluster restructuring in lung
adenocarcinomas (Fig. 3). In 6 of 14 cases, there is no evidence
for rDNA cluster rearrangement. In PHAZL-SA, SEBON-CL, and
IBINA-KE gene, cluster lengths in all of nontumor, tumor, and
blood samples are longer than the ∼1-Mb resolution limit of the
gels. This absence of resolved size differences in the gene clusters
from the tumor samples compared with the nontumor controls
indicates that these tumors did not undergo recombination-mediated gene cluster alterations, although we cannot preclude alterations in the unresolved gene cluster lengths larger than 1 Mb in
these patients. The banding patterns in MILST-BR, PARLA-CA,
and CEVAT-MA are also the same between tumor and either peripheral blood or normal lung, indicating gene cluster stability;
however, UGOBI-FO, KABIG-NI, and EVIEN-RA show evidence of
pretumor alteration with new major bands, but no new minor
banding. The remaining five tumors, TIPOR-PA, GLOAK-EU,
MEERY-BE, MUVID-DO, and FOBIK-TE, all show both new major
and minor intensity bands, consistent with a period of dysregu-
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lated recombination both before and immediately following commitment to clonal tumor cell expansion.
The colorectal tumor patients show a similar distribution of rDNA
cluster instability as the lung cancer patients. Of the 10 colon cancer
samples (Fig. 4), 4 appear stable (SAGOF-GR, FONET-VI, ARPIC-RO,
and EBETH-DA), 5 more show preclonal expansion alterations
(VOBLE-JO, DAPEB-MA, COBEZ-WI, RIZON-HE, and SNARG-GE),
whereas 1 shows both new major and minor bands indicative of
gene cluster restructuring both before and after tumor cell commitment (PULAB-GE). The process of metastasis does not necessarily
involve recombinational gene cluster restructuring, as seen in the
colon tumor from EBETH-DA, which was surgically recovered from
a colon metastasis to lung. Likewise, it is notable that unlike the lung
cancer patients, in nearly all of whom have a smoking history, rDNA
cluster alterations are also seen in colon cancer patient tumors from
either nonsmokers (RIZON-HE, PULAB-GE) or individuals with a
relatively modest smoking history (VOBLE-JO).
The rectal cancers follow a similar pattern (Fig. 5). Two of
four patients (CLIMP-HA and DOOVA-CL) show light stochastic
breakage but are otherwise gene cluster stable. Two other patient
tumors show evidence of either pre-expansion (BINTA-CH) or
preclonal and postclonal expansion (WIVIT-HE) gene cluster
instability. Our experience was that nontumor rectal tissue was difficult to work with; so generally, we compared tumor gene cluster
structure to that from peripheral blood.
Architectural rearrangements in the rDNA clusters are less frequent in the 12 pediatric leukemias we have examined (Fig. 6).

Figure 5. Rectal adenocarcinoma rDNA stability analysis. rDNA clusters
resolved up to 1 Mb in length (★). N, nontumor tissue; T, tumor tissue; B,
peripheral blood. , sample fragility; , new major bands found in tumors; ,
new minor bands found in tumors. Coded patient names are indicated below
each gel. Differentiation status of tumors: mod, moderately differentiated.
Pathologic staging of nonmetastatic tumors is indicated. Smoking history is given
in person-pack-years (ppy) or for a nonsmoker (no).
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Figure 6. Pediatric leukemia rDNA stability analysis. rDNA
clusters resolved up to 1 Mb in length (★). L, leukemia:
peripheral blood containing blasts; R, remission: peripheral
blood posttreatment with no detectable blasts; D, donor:
peripheral blood following engraftment of transplanted
bone marrow from an allogeneic donor. Coded patient
names are indicated below each gel. The percentage
of blasts in leukemia samples is indicated. Leukemic
classification: pre-B ALL, pre–B-cell acute lymphocytic
leukemia; mono ALL, monocytic acute myelogenous
leukemia; T-cell ALL, T-cell acute lymphocytic leukemia.

Comparing peripheral blood containing blasts before or shortly
after the initiation of treatment to peripheral blood from the
same patients in remission with no residual detectable blasts
after recovery from induction chemotherapy shows the same pat-

Cancer Res 2009; 69: (23). December 1, 2009

tern of bands in 10 of the 12 different pediatric patients. Evidence
of pre-expansion rearrangement is detected in NIPRY-JA and
RAMAH-LE, with novel band intensities proportional to the fraction
of blasts found in these patients' peripheral blood. PALT-BR is an
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interesting, if tragic, case. We first encountered this 5-year-old boy
in remission 3 years after a diagnosis of and treatment for pre–B-cell
acute lymphocytic leukemia before his allogeneic stem cell transplant. After his transplant, his peripheral blood shows the rDNA
cluster pattern of the engrafted donor marrow. Shortly after the
transplant, the patient relapses and we see a re-establishment of
his pretransplant rDNA cluster pattern 2 weeks before his death. Although this individual underwent years of intensive chemotherapy
and full body irradiation, his disease shows no evidence of rDNA
cluster instability (remission versus posttransplant leukemia rDNA
cluster pattern, ignoring the bands from the donor marrow).

ploidy commonly seen in adult solid tumors (21). Intriguingly, other highly self-similar clustered gene loci in the human genome (22)
express protein products found with relative specificity only in
cancer and in highly recombination-active tissues such as testis:
the so-called “CT” genes (23). We are actively pursing whether
these loci are also recombinationally destabilized in cancer and
with what potential clinical relevance.
From a predictive standpoint, because DNA double-strand
breaks are potent inducers of homologous recombination in human cells (24) and many chemotherapeutic agents exert their genotoxic effects through DNA double-strand breaks, the use of these
agents in tumors with dysregulated recombination may prove to
be problematic. Dysregulated recombination in tumor cells may
facilitate large-scale genomic restructuring in response to radiomimetic chemotherapy accelerating establishment of chemotherapeutic resistance. Similarly, exposure to genotoxic agents from
tobacco in potentially numerous precancerous cells with dysregulated recombination may contribute to the synchronous dissimilar
primary lung tumors sometimes found in heavy smokers.
We are continuing to follow and expand our enrolled patient
population to ascertain whether assaying rDNA restructuring in tumor cells has prognostic and/or predictive value. Specifically, now
that we can divide solid tumor cancer patients into two approximately evenly populated cohorts, based on whether tumors either
do or do not display evidence of dysregulated recombination, we
will determine whether dysregulated recombination is informative
with regard to risk of tumor recurrence, with the disease-free survival interval postsurgery, and with overall survival. For patients
that undergo adjuvant chemotherapy or radiation therapy postsurgery, we will also determine whether the degree of responsiveness
to adjuvant therapy is influenced by the presence of dysregulated
recombination in the primary tumors. The dysregulated recombination cohort can be further subdivided, based on the presence or
absence of minor banding in the tumor sample, into patients for
whom the tumor was still actively recombining the rDNA clusters
during the initial phase of tumor clonal expansion and into those
for whom dysregulated recombination appeared to be restricted to
the interval before primary tumor clonal expansion, allowing further fine-tuning of the potential clinical application of the assay.
In summary, we have detected structural alterations to the rRNA
gene clusters in over 50% of the adult solid tumors examined, making these genomic rearrangements one of the most common specific chromosomal alterations in adult solid tumors. The functional
significance of the rDNA for the capacity of tumor cells to produce
protein, as well as the potential sentinel biomarker nature of the
rDNA for recombination-driven genomic alterations involving other highly conserved low-copy repetitive genomic elements, suggests assaying rDNA cluster instability in tumors may prove to
have prognostic and/or predictive value.

Discussion
Of the solid tumors analyzed for rDNA cluster instability, the
overall frequency of any observed rDNA cluster alteration is 54%
(21 of 39: 95% confidence interval, 39–68% by adjusted Wald method). Thirty-one percent (12 of 39) showed alterations consistent
with preclonal expansion alterations only, and a further 23% (9
of 39) showed evidence of recombination-mediated rDNA cluster
alterations both before the start of clonal tumor expansion as well
as in the several rounds of cell division immediately following commitment to clonal expansion. No evidence of rDNA cluster instability was observed in 46% (18 of 39) of cases. Because the rDNA
clusters range in size up to 6 Mb and we only analyzed clusters
smaller than 1 Mb, the frequency of 54% observed gene cluster alterations is likely an underestimate.
Considering that the rDNA clusters only make up ∼0.5% of the diploid human genome, this alteration frequency of over 50% in human
solid tumors indicates that the rDNA clusters are extraordinarily sensitive indicators of the capacity for human cancer to use recombination to alter submicroscopic genomic structure, and that this
submicroscopic genomic restructuring is one of the most frequent
chromosomal aberrations found in nonhereditary solid tumors. In
comparison, rDNA alteration in pediatric leukemia is only found in
∼15% of cases. This frequency difference in cluster recombinational
restructuring between pediatric leukemia and adult solid tumors (P =
0.04 Fisher's two-tailed exact test) may reflect the adult tumors' progressive accumulation of genomic insults from both time and genotoxic environmental exposure, compared with more simple specific
translocation-driven disease in the pediatric patients.
The rDNA clusters are critical components of cellular metabolism, so recombinational dysregulation in the rDNA may directly alter the capacity for tumor cell growth. The hypermetabolic nature of
cancer cells requires expanded capacity for protein synthesis. Because rRNA production is rate limiting for the construction of
new ribosomes, instability in the rDNA clusters will allow for positive selection of subpopulations of cancer cells that have expanded
their rDNA complement. Upregulation of rRNA expression through
epigenetic derepression is already known in lung cancer (19), making selectable gene amplification of the rRNA an additional effective
mechanism for producing the large number of required ribosomes
in hypermetabolic, relatively rapidly dividing tumor cells.
In addition to its direct contribution to tumor cell metabolism,
instability of the rDNA may be indicative of broader recombination-based genomic instability in repetitive genomic elements
and may serve as a sentinel biomarker for genomic alteration mediated by recombination between other high-similarity low-copy
repeated sequences (20). For example, dysregulated recombination
causing genomic restructuring of centromeric α-satellite repeats
may result in centromeric dysfunction, contributing to the aneu-
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